Search
Regulatory Story
Company DCC PLC
TIDM DCC
Headline Results for the six months ended 30 September 2019
Released 07:00 12-Nov-2019
Number 0399T07

RNS Number : 0399T
DCC PLC
12 November 2019
 

 12 November 2019

DCC Reports Strong First Half Performance and

New US Health & Beauty Acquisition

 

DCC, the leading international sales, marketing and support services group, is today announcing its results for the six months ended 30 September 2019.

 

Highlights

2019

2018

% change

Revenue

£7.312bn

£7.418bn

-1.4%

Adjusted operating profit1,2

£162.6m

£141.9m

+14.5%

DCC LPG

£49.0m

£40.9m

+19.8%

DCC Retail & Oil

£59.7m

£56.3m

+6.0%

DCC Technology

£25.4m

£17.8m

+42.6%

DCC Healthcare

£28.5m

£26.9m

+5.8%

Adjusted earnings per share1,2

110.2p

107.1p

+3.0%

Interim dividend

49.48p

44.98p

+10.0%

Operating cash flow

£149.9m

£173.2m

 

                               

·    Strong first half performance with Group adjusted operating profit increasing by 14.5% (up 13.7% on a constant currency basis) to £162.6 million, in line with expectations. All divisions recording good profit growth in the seasonally less significant first half of the year.

 

·    Adjusted earnings per share up 3.0% to 110.2 pence, reflecting strong earnings growth being offset by the increased number of shares in issue following the equity placing in the prior year.

 

·     Interim dividend increased by 10% to 49.5 pence per share.

 

·    The Group continues to be active from a development perspective and has today separately announced the recent acquisition by DCC Healthcare of Ion Laboratories Inc, a Florida-based contract manufacturer of nutritional products for an enterprise value of approximately $60 million. The acquisition represents a significant step in DCC Healthcare's strategy to build a material presence in the attractive US health supplements and nutritional products market.

 

·    The Group balance sheet at 30 September 2019 remains very strong and liquid, with net debt (excluding   lease creditors) of £245.3 million, which will facilitate further development activity for the Group.

 

·   Notwithstanding the continuing uncertain macroeconomic outlook impacting the UK economy, and the Technology business in particular, the Group believes that the year ending 31 March 2020 will be another year of good operating profit growth and further development and will be broadly in line with current market consensus expectations.

 

1 The current financial period includes the impact of the adoption of IFRS 16 Leasesthe comparatives have not been restated in accordance with transitional guidelines. 

2 Excluding net exceptionals and amortisation of intangible assets. 

 

Commenting on the results, Donal Murphy, Chief Executive, said:

 

"I am pleased to report that the first half of the year has been another period of good growth and development for DCC. The business has performed strongly, with Group operating profit well ahead of the prior year and all divisions delivering good profit growth, despite the more difficult economic and market backdrop, particularly in the UK.

 

DCC Healthcare's acquisition of Ion Laboratories Inc in the US is a material step in the division's strategy to build a business of scale in the world's largest health supplements and nutritional products market. The US market is highly innovative, fragmented and growing strongly and, we believe, presents an exciting opportunity for the Group to develop, both organically and through acquisition, a leading market position in this attractive market.

 

The Group's significant development in recent years has resulted in DCC having the platforms, opportunities and capability to build the Group into a global leader in its chosen sectors.

 

Notwithstanding the continuing uncertain macroeconomic outlook impacting the UK economy, and the Technology business in particular, the Group believes that the year ending 31 March 2020 will be another year of good operating profit growth and further development and will be broadly in line with current market consensus expectations."

 

 

 

 

 

Presentation of results and dial-in / webcast facility

There will be a presentation of these results to analysts and fund managers at 9.00 am today in the London Stock Exchange.  The slides for this presentation can be downloaded from DCC's website, www.dcc.ie.

 

There will also be audio conference access to, and a live webcast of, the presentation.  The access details for the presentation are:

 

Ireland:               +353 (0)1 4319615           

UK:                      +44 (0) 8445718892         

International:    +44 (0) 2071 928000

Passcode:           6157159                               

Webcast Link:    https://edge.media-server.com/mmc/p/4uhsuse2 

              

 

This report, the webcast of the presentation and further information on DCC is available at www.dcc.ie.

 

For reference, please contact:

  Donal Murphy, Chief Executive

                  Tel: +353 1 2799 400

  Fergal O'Dwyer, Chief Financial Officer

        Email: investorrelations@dcc.ie

  Kevin Lucey, Head of Capital Markets

                                  Web: www.dcc.ie

 

 

 

 

For media enquiries: Powerscourt (Lisa Kavanagh) 

                  Tel: +44 207 250 1446

 

 

Group Results

A summary of the Group's results for the six months ended 30 September 2019 is as follows:

 

 

20191

2018

 

 

£'m

£'m

% change

 

 

 

 

Revenue

7,312

7,418

-1.4%

Adjusted operating profit2

 

 

 

DCC LPG

49.0

40.9

+19.8%

DCC Retail & Oil

59.7

56.3

+6.0%

DCC Technology

25.4

17.8

+42.6%

DCC Healthcare

28.5

26.9

+5.8%

Group adjusted operating profit2

162.6

141.9

+14.5%

Finance costs (net) and other

(26.7)

(22.1)

 

Profit before net exceptionals, amortisation of intangible assets and tax

135.9

119.8

+13.5%

Net exceptional items before tax and non-controlling interests

(45.7)

(6.3)

 

Amortisation of intangible assets

(32.6)

(27.6)

 

Profit before tax

57.6

85.9

 

Taxation

(15.4)

(14.0)

 

Profit after tax

42.2

71.9

 

Non-controlling interests

(4.5)

(3.9)

 

Attributable profit

37.7

68.0

 

Adjusted earnings per share2

110.2 pence

107.1 pence

+3.0%

Dividend per share

49.48 pence

44.98 pence

+10.0%

Operating cash flow

149.9

173.2

 

Net debt at 30 September (excluding lease creditors)

245.3

830.4

 

Lease creditors

286.4

2.0

 

Net debt at 30 September (including lease creditors)

531.7

832.4

 

 

 

 

 

1The current financial period includes the impact of the adoption of IFRS 16 Leases; the comparatives have not been restated in accordance with transitional guidelines. As anticipated, the Group adjusted operating profit reflects a benefit of £2.7 million, while finance costs reflect an incremental charge of £4.2 million from the adoption of IFRS 16, resulting in a net after-tax negative impact on earnings of approximately £1.2 million, or 1.3 pence per share.  See page 4 for further detail.

2 Excluding net exceptionals and amortisation of intangible assets.

 

 

 

 

 

 

 

 

Transition to IFRS 16

The Group transitioned to the new leasing standard, IFRS 16, with effect from 1 April 2019. In common with most companies, DCC has elected to adopt the modified retrospective approach, meaning that comparatives are not restated.

 

In transitioning to IFRS 16, the Group is capitalising approximately 2,000 leases. These 2,000 leases are with approximately 700 lessors, with no one lease or lessor relationship being individually significant. The applicable weighted average lease term is approximately four years. The capitalisation of the right to use assets underlying these leases has resulted in a 'Right-of-Use leased asset' of £286 million at 30 September 2019, with a related lease creditor of £286 million at the same date.

 

As anticipated, the transition to IFRS 16 resulted in a favourable impact on adjusted operating profit of approximately £2.7 million in the first half of the financial year, reflecting the replacement of operating lease charges with depreciation of a discounted right-of-use leased asset. It also resulted in an increase in net interest of approximately £4.2 million in the period reflecting the unwinding of the lease liability. Consequently, the net after-tax impact on earnings for the first six months of the financial year was a charge of approximately £1.2 million, or 1.3 pence per share.

 

Reporting currency

The Group's financial statements are presented in sterling. Results and cash flows of operations based in non-sterling jurisdictions have been translated into sterling at average rates for the year. The principal exchange rates used for the translation of results into sterling were as follows:

 

             Average rate

 

 

2019

2018

 

 

 

Stg£1=

Stg£1=

 

 

Euro

1.1265

1.1306

 

 

Danish Krone

8.4133

8.4245

 

 

Swedish Krona

11.9717

11.7550

 

 

Norwegian Krone

11.0116

10.8614

 

 

US Dollar

1.2620

1.3409

 

 

Hong Kong Dollar

9.8892

10.5233

 

 

 

The net impact of currency translation on the Group income statement versus the prior period was modest, with average sterling exchange rates weakening against the US Dollar and marginally weakening against euro.

 

Revenue

Overall, Group revenue decreased by 1.4% (1.7% decrease on a constant currency basis) to £7.3 billion.

 

DCC LPG sold 798,500 tonnes in the first half of the year, an increase of 7.7% on the prior year (7.1% on a like-for-like basis). The strong volume performance was set against weaker comparatives in the prior year, but included good organic volume growth in both the LPG and natural gas product sectors.

 

DCC Retail & Oil sold 5.93 billion litres of product in the first half, a 3.8% decline versus the prior year (4.9% on a like-for-like basis). The reduction reflected lower volumes in the UK, particularly in the lower margin marine and commercial sectors as the business actively exited high volume, lower margin relationships, but also reflected lower commercial activity generally, given the more difficult UK economic backdrop. Volumes across Continental Europe, Scandinavia and Ireland were in line with expectations.

 

Revenue excluding DCC LPG and DCC Retail & Oil increased by 11.7% (up 10.8% on a constant currency basis) to £2.1 billion and declined modestly organically, driven by a decline in revenue in the Technology business in the UK.  

 

Group adjusted operating profit

Group adjusted operating profit increased by 14.5% to £162.6 million (13.7% ahead on a constant currency basis), in the seasonally less significant first half of the year. The positive effect of IFRS 16 on Group adjusted operating profit was approximately 1.9% of the constant currency growth in the period. Approximately one-third of the remaining constant currency growth was organic.

 

DCC LPG recorded strong operating profit growth in the seasonally less significant first half of the year, with operating profit increasing to £49.0 million, 19.8% ahead of the prior year (18.6% on a constant currency basis), approximately three-quarters of which was organic. The performance was driven primarily by good organic volume growth and also the acquisition of Pacific Coast Energy.

 

In DCC Retail & Oil, operating profit increased by 6.0%, approximately one-third of which was organic. This good performance was driven by good organic profit growth from the businesses in France and Denmark with the remaining businesses performing in line with expectations.

 

Operating profit in DCC Technology was significantly ahead of the prior year, increasing by 42.6% (38.1% on a constant currency basis) in the seasonally less significant first half of the financial year. This performance was driven by the contribution from acquisitions completed in both the current and prior year and profits declined organically, with the UK business negatively impacted by increasingly difficult market conditions, given the economic environment, particularly in the consumer and enterprise channels. Good profit growth was achieved in North America, Ireland, the Middle East and Continental Europe.

 

DCC Healthcare recorded a good performance in the first half of the year, generating operating profit growth of 5.8%, over three-quarters of which was organic. DCC Vital performed well and generated good growth in the pharma sector in Ireland. DCC Health & Beauty Solutions generated strong growth in premium skincare products and good growth across its nutritional products, particularly in liquids and soft gel formats.

 

Finance costs (net)

Net finance and other costs increased to £26.7 million (2018: £22.1 million). The increase primarily reflects the impact of IFRS 16 in the current period of £4.2 million. The average net debt, excluding lease creditors, in the period was £349 million, compared to an average net debt of £914 million in the prior year. The decrease in average net debt excluding lease creditors reflects the benefit of the equity issuance completed in October 2018. The Group's gross private placement debt, which is the primary driver of finance costs, increased modestly versus the prior year.

 

Profit before net exceptional items, amortisation of intangible assets and tax

Profit before net exceptional items, amortisation of intangible assets and tax increased by 13.5% (12.5% ahead on a constant currency basis) to £135.9 million. 

 

Net exceptional items before tax and non-controlling interests and amortisation of intangible assets

The Group recorded a net exceptional charge before tax and non-controlling interests of £45.7 million in the first six months of the year as follows:

 

 

£'m

Loss on disposal 

34.3

Restructuring and integration costs and other

6.1

Acquisition and related costs

4.9

IAS 39 mark-to-market ineffectiveness charge

0.4

Net exceptional charge

45.7

 

In September 2019, DCC Healthcare completed the disposal of DCC Vital's UK generic pharma activities and related manufacturing facility in Ireland (Kent Pharma and Athlone Laboratories). The disposal sharpens the strategic focus of DCC Vital, allowing it to concentrate on those areas where it has market-leading positions and sustainable competitive advantage, in particular in the sales, marketing and distribution of medical products in Britain and Ireland. Whilst part of the DCC Group, the cashflows generated by the disposed business more than recovered its acquisition cost, however, the transaction will result in a loss on disposal of £34.3 million, principally representing a non-cash impairment of the goodwill recognised on the initial acquisition of the business.

 

Restructuring and integration costs and other of £6.1 million principally comprise the ongoing dual running costs relating to the UK SAP implementation which is live in an element of the UK business and to which the remaining components of the business will transition on a phased basis shortly following the end of the financial year. It also includes a restructuring charge relating to the LPG business in Britain, following acquisition activity (including the acquisition of Countrywide and a number of small dealers) in prior periods.

 

Acquisition and related costs include the professional fees and tax costs (such as stamp duty) relating to the evaluation and/or completion of acquisition opportunities and amounted to £4.9 million.

 

Most of the Group's debt has been raised in the US private placement market and swapped, where appropriate, using long-term interest and cross currency interest rate derivatives, to both fixed and floating rate sterling and euro. The level of ineffectiveness calculated under IAS 39 on the fair value and cash flow hedge relationships is charged or credited as an exceptional item. In the six months ended 30 September 2019, this amounted to an exceptional non-cash charge of £0.4 million. Following this charge, the cumulative net exceptional charge taken in respect of the Group's outstanding US private placement debt and related hedging instruments is £1.6 million. This, and any subsequent similar non-cash charges or gains, will net to zero over the remaining term of this debt and the related hedging instruments.  

 

The charge for the amortisation of acquisition related intangible assets increased to £32.6 million from £27.6 million in the prior year, with the increase reflecting acquisitions completed in the prior year.

 

Profit before tax

Profit before tax decreased to £57.6 million.

 

Taxation

The effective tax rate for the Group in the first half of the year of 17.0% is based on the anticipated mix of profits for the full year and compares to a full year effective tax rate in the prior year of 17.0%.

 

Adjusted earnings per share

Adjusted earnings per share increased by 3.0% to 110.2 pence, with the growth in profit before exceptional items and goodwill amortisation of 13.5% being offset by the increased number of shares in issue following the equity placing, which was successfully completed in the prior year.

 

Dividend

The Board has decided to pay an interim dividend of 49.48 pence per share, which represents a 10.0% increase on the prior year interim dividend of 44.98 pence per share. This dividend will be paid on 11 December 2019 to shareholders on the register at the close of business on 22 November 2019.

 

 

Cash flow  

As with its operating profit, the Group's operating cash flow is significantly weighted towards the second half of the year. The cash flow of the Group for the six months ended 30 September 2019 can be summarised as follows:

 

Six months ended 30 September

 

 

2019

2018

 

 

 

£'m

£'m

 

 

 

 

 

Adjusted operating profit

 

 

162.6

141.9

 

 

 

 

 

Increase in working capital

 

 

(98.1)

(25.7)

Depreciation and other

 

 

85.4

57.0

 

 

 

 

 

Operating cash flow

 

 

149.9

173.2

Repayment of lease creditors1

 

 

                (31.8)

 -

Capital expenditure (net)

 

 

(87.7)

(82.1)

 

 

 

 

 

Free cash flow1

 

 

30.4

91.1

 

 

 

 

 

Net interest, tax paid and other

 

 

(46.0)

(34.2)

 

 

 

 

 

Free cash flow after interest and tax

 

 

(15.6)

56.9

 

 

 

 

 

Acquisitions

 

 

(118.3)

(270.3)

Dividends

 

 

(90.9)

(73.2)

Exceptional items (net) and disposals

 

 

25.4

(11.1)

Share issues

 

 

0.3

1.1

 

 

 

 

 

Net outflow

 

 

(199.1)

(296.6)

 

 

 

 

 

Opening net debt

 

 

(18.4)

(542.7)

Translation and other

 

 

(20.1)

6.9

 

 

 

(237.6)

(832.4)

 

 

 

 

 

IFRS 16 transition adjustment at 1 April 2019

 

 

(294.1)

-

 

 

 

 

 

Closing net debt (including lease creditors)

 

 

(531.7)

(832.4)

 

 

 

 

 

Analysis of closing net debt (including lease creditors):

 

 

Net debt at 30 September (excluding lease creditors)

(245.3)

(830.4)

Lease creditors at 30 September

 

 

(286.4)

(2.0)

 

(531.7)

(832.4)

 

 

 

1 Following the adoption of IFRS 16, Leases, the Group has redefined 'Free Cash Flow' to include repayment of lease creditors which ensures that the Group's reported Free Cash Flow is consistent with those previously reported and consequently the comparative measure has not been restated.

 

 

 

 

Working capital increased by £98.1 million over the six-month period from 31 March 2019, driven by seasonal working capital requirements, lower supply chain financing utilisation and the increasing scale of the Group's activities. The value of working capital at 30 September 2019 was £110.1 million versus £60.0 million at 30 September 2018, which reflects the completion of acquisitions since the prior year and the increasing scale of the Group. Overall working capital days at 30 September 2019 were 2.4 days sales, which, excluding completed acquisitions, were broadly in line with the prior year (2018: 1.3 days sales). DCC Technology selectively uses supply chain financing solutions to sell, on a non-recourse basis, a portion of its receivables relating to certain larger supply chain/sales and marketing activities. The level of supply chain financing at 30 September 2019 was £189.3 million (2018: £211.1 million) and supply chain financing had a positive impact on Group working capital days of 4.1 days (30 September 2018: 4.4 days).

 

Net capital expenditure for the six months amounted to £87.7 million (2018: £82.1 million), was net of disposal proceeds of £4.3 million, and reflects continued investment in development initiatives across the Group. In the current year, investments in DCC LPG primarily comprised investment in relation to the Avonmouth LPG storage facility in the UK and further development expenditure to support the continued growth of the business including conversion of oil customers to LPG. In the Retail & Oil division, there was continued investment in new retail sites and site upgrades including capital expenditure in relation to the project to optimise the depot network in the UK to bring greater network and capital efficiency over time. The majority of the capital expenditure in DCC Technology relates to the SAP implementation which is ongoing in Exertis UK. In DCC Healthcare, the capital expenditure primarily relates to the previously announced investment in the expansion of the soft gel facility in South Wales, the construction of which is nearing completion and the commissioning process will commence shortly. Net capital expenditure exceeded the depreciation charge (excluding right-of-use leased assets) in the six months by £29.7 million.

 

Free cash flow in the six months ended 30 September 2019 of £30.4 million compares to £91.1 million in the prior year.

 

Total cash spend on acquisitions in the six months to 30 September 2019

The total cash spend on acquisitions in the six months ended 30 September 2019 was £118.3 million. This included the payment of deferred and contingent acquisition consideration previously provided of £24.5 million, completion of the acquisition of Pacific Coast Energy by DCC LPG, the completion of Amacom and Comm-Tec by DCC Technology and the completion of a number of small bolt-on acquisitions in DCC Retail & Oil and DCC Healthcare.

 

Committed acquisition and capital expenditure

Committed acquisition and capital expenditure in the period amounted to £163.4 million as follows:

 

 

       Acquisitions

Capex

 

       £'m

      £'m

            £'m

DCC LPG

1.5

32.4

33.9

DCC Retail & Oil

3.5

33.9

37.4

DCC Technology

6.1

9.8

15.9

DCC Healthcare

64.6

11.6

76.2

 

 

 

 

Total

75.7

87.7

163.4

 

Acquisition activity

Acquisition expenditure committed by the Group since the announcement of 2019 Final Results in May 2019 amounted to £75.7 million and included:

 

DCC Healthcare

As separately announced today, DCC Healthcare has acquired Ion Laboratories, Inc ('Ion'), a Florida-based contract manufacturer of nutritional products for an enterprise value of approximately $60 million. This acquisition represents a significant step in DCC Health & Beauty Solutions' strategy to build a material presence in the attractive US health supplements and nutritional products market. This acquisition follows the acquisition of Elite One Source in February 2018, and will significantly enhance DCC Health & Beauty Solution's service offering to customers in the US market, the world's largest health supplement and nutritional products market. 

 

Ion has a broad product format capability encompassing tablets, capsules, powders and liquids across a variety of product categories including herbal and botanical products, probiotics and liquid nutritionals. In addition, Ion is currently commissioning a new nutritional gummies manufacturing line which will provide DCC Health & Beauty Solutions with capability in this fast growth category. Ion operates from well invested facilities which comply with FDA cGMP (current Good Manufacturing Practices) and Health Canada standards. The business is led by an experienced management team, employs 360 people and the business has annual revenues of approximately $80 million.

 

In addition, DCC Vital completed a number of complementary bolt-on acquisitions in Britain which have expanded its product portfolio and strengthened its market presence.  SP Services is a leading supplier of medical consumables and equipment for first aid, ambulance, paramedic and rescue professionals in the 'blue light' and occupational health sectors. VacSax is a small British manufacturer and supplier of disposable suction devices used in operating theatres and hospitals.

 

DCC Retail & Oil

DCC Retail & Oil completed a number of small complementary bolt-on acquisitions in Britain during the period. These acquisitions have been successfully integrated into the existing business.

 

DCC Technology

DCC Technology acquired two small businesses during the period, a managed service business in Ireland and a Pro-AV specialist in the Benelux region. Although small, both acquisitions support DCC Technology's strategy to continuously enhance the service offering it provides to its customers and suppliers.

 

Disposal

DCC Healthcare

Kent Pharma and Athlone Laboratories

In September 2019, DCC Vital completed the disposal of its UK generic pharma activities and related manufacturing facility in Ireland (Kent Pharma and Athlone Laboratories). The disposal sharpens the strategic focus of DCC Vital, allowing it to concentrate on those areas where it has market-leading positions and sustainable competitive advantage, in particular in the sales, marketing and distribution of medical products in Britain and Ireland. DCC Vital will also continue to develop its pharma activities in Ireland which encompass a market leadership position in the procurement and sales of exempt medicinal products and agency distribution into the hospital and retail pharmacy segments.

 

Financial strength

An integral part of the Group's strategy is the maintenance of a strong and liquid balance sheet which, amongst other benefits, enables it to take advantage of development opportunities as they arise. At 30 September 2019, the Group had net debt (excluding lease creditors) of £0.25 billion, being term debt of £1.82 billion, and cash resources, net of overdrafts, of £1.57 billion. Lease creditors at the same date amounted to £0.28 billion. The Group's outstanding term debt at 30 September 2019, which has been raised in the US private placement market, had an average maturity of 6.2 years, with an implied average credit margin of 1.69% over Euribor/Libor. In April 2019, DCC successfully drew down a private placement issuance of approximately £350 million, the proceeds of which will be used to repay maturing private placement debt.

 

Outlook

Notwithstanding the continuing uncertain macroeconomic outlook impacting the UK economy, and the Technology business in particular, the Group believes that the year ending 31 March 2020 will be another year of good operating profit growth and further development and will be broadly in line with current market consensus expectations.

 

 

Performance Review - Divisional Analysis

 

DCC LPG

2019

2018

% change

Volumes (thousand tonnes)

798.5kT

741.6kT

+7.7%

Operating profit

£49.0m

£40.9m

+19.8%

Operating profit per tonne

£61.40

£55.16

 

 

DCC LPG recorded strong operating profit growth in the seasonally less significant first half of the year. Operating profit increased to £49.0 million, 19.8% ahead of the prior year (18.6% ahead on a constant currency basis), approximately three-quarters of which was organic. The performance was driven by good organic volume growth and the acquisition of Pacific Coast Energy in the US, which completed in May 2019.

 

DCC LPG sold 798,500 tonnes in the first half of the year, an increase of 7.7% on the prior year (7.1% on a like-for-like basis). The strong volume performance was set against weaker comparatives in the prior year and, as anticipated, operating profit per tonne increased versus the prior year. This reflected a more benign cost of product environment during the first six months of the year (versus a prior year which had been impacted by sustained rising cost of product) and strong cost control, which more than offset the mix effect of increased natural gas volumes.

 

The French business performed in line with expectations during the first half of the year and has continued to make progress in developing its offering in adjacent product areas, broadening its position in the French energy market. The continued rollout of the 'Click & Collect' cylinder offering has been a positive development for the LPG business, offering an additional route to market. The overall performance in France benefited from strong organic growth in the natural gas B2B sector, driven by good business development with new customers, and the business continues to grow its presence in the B2C natural gas and power sector.

 

In Britain & Ireland, the business performed strongly, achieving organic volume growth and also benefiting from good procurement and cost control. The German business delivered good LPG volume growth and was successful in winning new customers through its newly launched online platform, while the business in Hong Kong & Macau also performed in line with expectations, notwithstanding the impact of the ongoing protests in the region.

 

The US business performed well during the first half of the year and has fully integrated Pacific Coast Energy, acquired in April 2019, significantly strengthening its footprint in the north west of the US.

 

DCC LPG has substantial operations in ten countries and is very well placed to continue its development both in existing and new territories, as well as expanding its position in adjacencies, which broadens its service offering to its customers.

 

 

 

DCC Retail & Oil

2019

2018

% change

Volumes (billion litres)

5.930bn

6.157bn

-3.8%

Operating profit

£59.7m

£56.3m

+6.0%

Operating profit per litre

1.01ppl

0.91 ppl

 

 

DCC Retail & Oil performed in line with expectations in the first half of the financial year and delivered good operating profit growth of 6.0%, approximately one-third of which was organic. 

 

DCC Retail & Oil sold 5.93 billion litres of product in the first half, a 3.8% decline on the prior year (4.9% on a like-for-like basis). The reduction reflected lower volumes in Britain, particularly in the lower margin marine and commercial sectors as the business actively exited some high volume, lower margin, relationships but also reflected lower commercial activity generally, given the more difficult UK economic backdrop. Volumes across Continental Europe, Scandinavia and Ireland were in line with expectations.

 

In Britain and Ireland, the business performed in line with expectations, delivering organic profit growth. The impact of reduced marine and commercial volumes was partially offset by increased penetration of premium fuels, including premium heating oil, and a good cost performance. The business continues to make good progress in expanding its retail network, as well as developing into adjacent areas, such as lubricants, having now successfully integrated the two modest lubricant blending businesses acquired in the prior year. In addition, the business has continued to develop its HGV truck stop network and enhance its offering of additional services to HGVs at these truck stops, such as secure parking and truck washes. The Fuel Card business delivered good organic profit growth, notwithstanding the more difficult economic environment impacting the commercial sector of the market.

 

In Scandinavia, the Danish business continued to deliver strong organic profit growth, driven by a good performance in retail fuels. In July 2019, the business entered into a new branded marketing and distribution agreement with Shell Aviation, which involved Shell taking a stake in the existing Danish aviation operations, giving the business access to Shell's global network and settlements platform, further strengthening DCC Retail & Oil's presence in the aviation fuels market. The businesses in both Norway and Sweden performed in line with expectations.

 

The French business delivered strong organic profit growth, reflecting a continued focus on business development and customer engagement following the successful implementation of customer-centred initiatives in the prior year including a loyalty programme, fuel differentiation through Esso's Synergy Fuels, and an improved car wash offering. The business in Austria performed in line with expectations.

 

DCC Retail & Oil has substantial operations in eight countries and has developed a low-cost and scalable platform to grow the business in existing and new territories. 

 

 

DCC Technology

2019

2018

% change

Revenue

£1.795bn

£1.588bn

+13.1%

Operating profit

£25.4m

£17.8m

+42.6%

Operating margin

1.4%

1.1%

 

 

DCC Technology achieved very strong operating profit growth in the seasonally less significant first half of the year. Operating profit increased by 42.6% (38.1% on a constant currency basis) with the performance driven by the contribution from acquisitions completed in both the current and prior years. Operating profit declined organically, reflecting weakness in the UK market.

 

During the first half of the year, the UK business was increasingly impacted by general weakness in the UK technology market, reflecting the more difficult economic environment of recent months. This slowdown particularly impacted demand in the consumer and enterprise channels. Following the pilot transition of a component of the UK business to the new ERP system last year, the remainder of the business will transition to the new ERP system on a phased basis shortly following the end of the financial year. The upgrade is expected to significantly enhance the capability of the business to service both its customers and suppliers. The business in Ireland performed well, generating good operating profit growth on the back of a strong retail market and an expansion of its B2B service offering.

 

The business in the Nordics generated strong revenue growth, especially in the AV and IT product categories, and continues to drive efficiencies on the back of investments made in the operating infrastructure in the prior year. In Western Europe, the acquisition of Amacom, which services retailers across the Netherlands, has performed well since its acquisition in June 2019 and will provide additional service capability to support the growth of DCC Technology's consumer proposition. The B2B business also performed in line with expectations and continues to invest in its audio-visual proposition, with the business' offering in this area being further supported by the recent acquisition of Comm-Tec in Germany and a small bolt-on acquisition in the Benelux region. The business in the Middle East performed well and continued its track record of achieving organic revenue and operating profit growth.

 

During the prior year, DCC Technology acquired both Stampede and Jam, providing DCC with platforms for growth and development in North America in the Pro AV, Pro Audio and consumer electronics markets. These acquisitions represented a significant step in DCC Technology's strategy to extend its geographic footprint and product range, strengthening its partnership with existing suppliers while also broadening its base of customers and suppliers. Both businesses have been integrated successfully and traded in line with expectations during the first half of the year delivering organic profit growth. The good performance was driven by strong demand for display and projector products from the hospitality and government sectors in the US in particular, and the business also saw good demand for Pro Audio and professional event lighting products.  

  

Following an active period of development over the last eighteen months, DCC Technology is building an international business of scale and has excellent platforms for further development in its chosen markets.

 

 

DCC Healthcare

2019

2018

% change

Revenue

£287.3m

£275.9m

+4.1%

Operating profit

£28.5m

£26.9m

+5.8%

Operating margin

9.9%

9.8%

 

 

DCC Healthcare recorded a good performance in the first half of the year, generating operating profit growth of 5.8%, approximately three-quarters of which was organic. During the period, the business also made material progress in sharpening its strategic focus by divesting its UK generic pharma activities and enhancing its market positions through a number of bolt-on acquisitions. Subsequent to the half-year end, in November 2019, DCC Health & Beauty Solutions took a further step in its strategy to build a significant presence in the US market, completing the acquisition of Ion, a Florida-based contract manufacturer of nutritional products.

 

DCC Vital, which is focused on the sales and marketing of medical products and pharmaceuticals to healthcare providers in Britain and Ireland, performed well in the first half of the year and enhanced its strategic positioning. In the Irish market, the business generated good growth in the pharma sector, particularly in sales of blood plasma products and exempt medicinal products. In Britain, the business performed robustly against a market background which was impacted by some destocking post the original March Brexit deadline, as well as continued public healthcare funding constraints. During the period, DCC Vital expanded its product portfolio and strengthened its market presence by completing a number of small bolt-on acquisitions in the medical devices and primary care sectors in Britain.

 

In September 2019, DCC Vital completed the disposal of its UK generic pharma activities (and related beta lactam antibiotic manufacturing facility in Ireland). This disposal allows DCC Vital to focus on those areas where it has strong market positions and sustainable competitive advantage, including further developing its presence in the primary care sector in Britain and continuing to scale its medical devices activities.

 

DCC Health & Beauty Solutions, which provides outsourced solutions to international nutrition and beauty brand owners, generated good sales growth in the first half of the year. The business generated strong growth in premium skincare products and good growth across its nutritional product formats, particularly liquids and soft gels, despite the impact of some destocking from certain customers. Profit growth was held back by some short-term costs required to onboard new customer and product wins in the beauty sector, as well as investments made to enhance operational capability and increase capacity generally. DCC Health & Beauty Solutions made good progress across a range of capacity expansion projects, most notably the expansion of its soft gel encapsulation plant in Wales. The construction of the plant is nearing completion and the commissioning process will begin shortly.

 

The acquisition of Ion in November 2019 is another significant step in DCC Health & Beauty Solutions ambition to build a leading contract manufacturing business in the US, to complement its existing presence in Europe. The US is the largest market in the world for health supplements and nutritional products and is an innovative, growing and fragmented market. Ion will add new customer relationships and new product format capability in the US. Ion has a broad product format capability encompassing tablets, capsules, powders and liquids. The business is currently commissioning a nutritional gummies manufacturing line which will provide DCC Health & Beauty Solutions with an entry into this fast growth product category. Ion will work closely with Elite One Source in Montana and DCC Health & Beauty Solutions' European business to cross-sell the full breadth of DCC Health & Beauty Solutions' comprehensive service offering.

 

 

 

Forward-looking statements

This announcement contains some forward-looking statements that represent DCC's expectations for its business, based on current expectations about future events, which by their nature involve risk and uncertainty. DCC believes that its expectations and assumptions with respect to these forward-looking statements are reasonable; however, because they involve risk and uncertainty as to future circumstances, which are in many cases beyond DCC's control, actual results or performance may differ materially from those expressed in or implied by such forward-looking statements.

 

Principal risks and uncertainties

The Board of DCC is responsible for the Group's risk management and internal control systems, which are designed to identify, manage and mitigate potential material risks to the achievement of the Group's strategic and business objectives. The Board has approved a Risk Management Policy which sets out delegated responsibilities and procedures for the management of risk across the Group.

 

The principal risks and uncertainties facing the Group in the short to medium term, as set out on pages 17 to 20 of the 2019 Annual Report (together with the principal mitigation measures), continue to be the principal risks and uncertainties facing the Group for the remaining six months of the financial year.

 

This is not an exhaustive statement of all relevant risks and uncertainties. Matters which are not currently known to the Board or events which the Board considers to be of low likelihood could emerge and give rise to material consequences. The mitigation measures that are maintained in relation to these risks are designed to provide a reasonable and not an absolute level of protection against the impact of the events in question.

 

 

Group Income Statement

                                                                                                                                                                                        

 

 

Unaudited 6 months ended

 

Unaudited 6 months ended

 

Audited year ended

 

 

30 September 2019

 

30 September 2018

 

31 March 2019

 

 

Pre exceptionals

Exceptionals

(note 6)

 

Total

 

Pre exceptionals

Exceptionals

(note 6)

 

Total

 

Pre exceptionals

Exceptionals

(note 6)

 

Total

 

Notes

£'000

£'000

£'000

 

£'000

£'000

£'000

 

£'000

£'000

£'000

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue 

5

7,311,721

-

7,311,721

 

7,418,009

-

7,418,009

 

15,226,893

-

15,226,893

Cost of sales

 

(6,510,346)

-

(6,510,346)

 

(6,704,752)

-

(6,704,752)

 

(13,589,254)

-

(13,589,254)

Gross profit

 

801,375

-

801,375

 

713,257

-

713,257

 

1,637,639

-

1,637,639

Administration expenses

 

(249,874)

-

(249,874)

 

(217,752)

-

(217,752)

 

(410,388)

-

(410,388)

Selling and distribution expenses

(387,697)

-

(387,697)

 

(354,174)

-

(354,174)

 

(793,514)

-

(793,514)

Other operating income

 

15,622

241

15,863

 

13,985

112

14,097

 

45,600

2,537

48,137

Other operating expenses

 

(16,865)

(45,570)

(62,435)

 

(13,398)

(10,403)

(23,801)

 

(18,815)

(30,722)

(49,537)

Adjusted operating profit

162,561

(45,329)

117,232

 

141,918

(10,291)

131,627

 

460,522

(28,185)

432,337

Amortisation of intangible assets

(32,664)

-

(32,664)

 

      (27,569)

-

(27,569)

 

(63,312)

-

(63,312)

Operating profit

5

129,897

(45,329)

84,568

 

114,349

(10,291)

104,058

 

397,210

(28,185)

369,025

Finance costs

 

(49,427)

(371)

(49,798)

 

(40,122)

-

(40,122)

 

(83,595)

-

(83,595)

Finance income

 

22,324

-

22,324

 

17,720

3,974

21,694

 

36,980

4,307

41,287

Equity accounted investments' profit after tax

469

-

469

 

248

-

248

 

717

-

717

Profit before tax

 

103,263

(45,700)

57,563

 

92,195

(6,317)

85,878

 

351,312

(23,878)

327,434

Income tax expense

7

(15,414)

44

(15,370)

 

(13,396)

(628)

(14,024)

 

(55,617)

(685)

(56,302)

Profit after tax for the financial period                      

  87,849

(45,656)

42,193

 

         78,799

(6,945)

71,854

 

295,695

(24,563)

271,132

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit attributable to:

 

 

 

 

 

 

 

 

 

 

 

 

Owners of the Parent Company

83,304

(45,617)

37,687

 

74,947

(6,945)

68,002

 

287,156

(24,563)

262,593

Non-controlling interests

 

4,545

(39)

4,506

 

3,852

-

3,852

 

8,539

-

8,539

 

 

87,849

(45,656)

42,193

 

78,799

(6,945)

71,854

 

295,695

(24,563)

271,132

Earnings per ordinary share

 

 

 

 

 

 

 

 

 

 

Basic earnings per share

8

 

 

38.34p

 

 

 

76.15p

 

 

 

280.14p

Diluted earnings per share

8

 

 

38.26p

 

 

 

76.02p

 

 

 

279.73p

Adjusted basic earnings per share

8

 

 

110.22p

 

 

 

107.05p

 

 

 

358.16p

Adjusted diluted earnings per share

8

 

 

109.99p

 

 

 

106.87p

 

 

 

357.63p

 

 

 

 

 

 

 

 

 

 

 

 

 

The current financial period includes the impact of the adoption of IFRS 16 Leases; the comparatives have not been restated in accordance with transitional guidelines.

Group Statement of Comprehensive Income

 

 

 

Unaudited

 

Unaudited

 

Audited

 

 

 

6 months

 

6 months

 

year

 

 

 

ended

 

ended

 

ended

 

 

 

30 Sept.

 

30 Sept.

 

31 March

 

 

 

2019

 

2018

 

2019

 

 

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

Group profit for the period

 

42,193

 

71,854

 

271,132

 

 

 

 

 

 

 

 

 

Other comprehensive income:

 

 

 

 

 

 

Items that may be reclassified subsequently to profit or loss

 

 

 

 

 

 

Currency translation

 

43,742

 

38,005

 

5,649

 

Movements relating to cash flow hedges

 

(9,702)

 

26,532

 

1,555

 

Movement in deferred tax liability on cash flow hedges

 

1,650

 

(4,510)

 

(264)

 

 

35,690

 

60,027

 

6,940

 

Items that will not be reclassified to profit or loss

 

 

 

 

 

 

Group defined benefit pension obligations:

 

 

 

 

 

 

- remeasurements

(5,513)

 

2,928

 

(1,346)

 

- movement in deferred tax asset

937

 

(489)

 

223

 

 

(4,576)

 

2,439

 

(1,123)

 

 

 

 

 

 

 

 

Other comprehensive income for the period, net of tax

31,114

 

62,466

 

5,817

 

 

 

 

 

 

 

 

 

Total comprehensive income for the period

 

73,307

 

134,320

 

276,949

 

 

 

 

 

 

 

 

 

Attributable to:

 

 

 

 

 

 

 

Owners of the Parent Company

 

67,452

 

129,975

 

269,387

 

Non-controlling interests

 

5,855

 

4,345

 

7,562

 

 

 

 

 

 

 

 

 

 

 

73,307

 

134,320

 

276,949

 

 

 

 

 

 

 

 

 

                           
 

Group Balance Sheet

 

 

 

 

 

 

 

 

 

Unaudited

 

Unaudited

 

Audited

 

 

30 Sept.

 

30 Sept.

 

31 March

 

 

2019

 

2018

 

2019

 

Notes

£'000

 

£'000

 

£'000

ASSETS

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

Property, plant and equipment

 

1,047,558

 

980,731

 

996,536

Right-of-use leased assets

12

285,962

 

-

 

-

Intangible assets and goodwill

 

2,117,107

 

2,136,655

 

2,069,558

Equity accounted investments

 

27,273

 

24,933

 

24,233

Deferred income tax assets

 

26,792

 

26,872

 

26,142

Derivative financial instruments

 

209,049

 

119,661

 

143,554

 

 

3,713,741

 

3,288,852

 

3,260,023

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Inventories

 

736,480

 

728,648

 

678,006

Trade and other receivables

 

1,471,835

 

1,459,337

 

1,517,507

Derivative financial instruments

 

42,331

 

78,232

 

67,987

Cash and cash equivalents

 

1,675,517

 

977,571

 

1,554,093

 

 

3,926,163

 

3,243,788

 

3,817,593

 

 

 

 

 

 

 

Total assets

 

7,639,904

 

6,532,640

 

7,077,616

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EQUITY

 

 

 

 

 

 

Capital and reserves attributable to owners of the Parent Company

 

 

 

 

Share capital

 

17,422

 

15,455

 

17,422

Share premium

 

882,881

 

281,587

 

882,561

Share based payment reserve

10

32,392

 

25,315

 

28,706

Cash flow hedge reserve

10

(22,939)

 

5,844

 

(14,887)

Foreign currency translation reserve

10

150,115

 

138,608

 

107,722

Other reserves

10

932

 

932

 

932

Retained earnings

 

1,314,696

 

1,231,736

 

1,368,250

Equity attributable to owners of the Parent Company

 

2,375,499

 

1,699,477

 

2,390,706

Non-controlling interests

 

50,467

 

39,604

 

42,821

Total equity

 

2,425,966

 

1,739,081

 

2,433,527

 

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

Borrowings

 

1,849,457

 

1,547,012

 

1,441,904

Lease creditors

12

232,770

 

1,462

 

452

Derivative financial instruments

 

2,187

 

7,489

 

1,122

Deferred income tax liabilities

 

172,783

 

196,434

 

174,250

Post employment benefit obligations

13

3,200

 

(4,515)

 

(1,397)

Provisions for liabilities

 

279,295

 

283,025

 

269,580

Acquisition related liabilities

 

84,692

 

86,118

 

73,586

Government grants

 

336

 

348

 

342

 

 

2,624,720

 

2,117,373

 

1,959,839

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Trade and other payables

 

2,112,083

 

2,134,197

 

2,218,838

Current income tax liabilities

 

41,207

 

23,107

 

49,799

Borrowings

 

298,602

 

438,584

 

331,124

Lease creditors

12

53,640

 

547

 

449

Derivative financial instruments

 

21,985

 

12,726

 

9,008

Provisions for liabilities

 

43,183

 

40,809

 

47,208

Acquisition related liabilities

 

18,518

 

26,216

 

27,824

 

 

2,589,218

 

2,676,186

 

2,684,250

Total liabilities

 

5,213,938

 

4,793,559

 

4,644,089

 

 

 

 

 

 

 

Total equity and liabilities

 

7,639,904

 

6,532,640

 

7,077,616

 

 

 

 

 

 

 

Net debt included above (excluding lease creditors)

11

(245,334)

 

(830,347)

 

(17,524)

 The current financial period includes the impact of the adoption of IFRS 16 Leases; the comparatives have not been restated in accordance with transitional guidelines.

 

Group Statement of Changes in Equity

 

For the six months ended 30 September 2019

Attributable to owners of the Parent Company

 

 

 

 

 

 

Other

 

Non-

 

 

Share

Share

Retained

reserves

 

controlling

Total

 

capital

premium

earnings

(note 10)

Total

interests

equity

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

 

 

 

 

At 1 April 2019

        17,422

882,561

1,368,250

  122,473

2,390,706

          42,821

2,433,527

Profit for the period

-

-

        37,687

              -       

     37,687       

             4,506

     42,193     

Currency translation

                   -   

                        -

                    -

      42,393

     42,393      

             1,349

     43,742        

Group defined benefit pension obligations:

                       

                            

                        

 

 

 

 

- remeasurements

                 -

-

          (5,513)

             -

 (5,513)

                    -

  (5,513)

- movement in deferred tax asset

                 -

-

                937

              -

       937

                    -

       937

Movements relating to cash flow hedges

                 - 

-

                    -

  (9,702)

  (9,702)

                     -      

    (9,702)

Movement in deferred tax liability on cash flow hedges

                 -

-

                  -

1,650

     1,650

                     -              

      1,650

Total comprehensive income

                 -

-

        33,111

      34,341

67,452

             5,855

73,307

Re-issue of treasury shares

                   -

320

                   -

-

           320     

                    -

        320

Share based payment

                  -

-

               -

         3,686

       3,686

                  -

3,686

Sale of equity interest to non-controlling interest

                 -

-

           4,306

               -

 4,306

             1,791

  6,097

Dividends

                  -

-

       (90,971)

              -

(90,971)

                 -

(90,971)

At 30 September 2019

        17,422

882,881

1,314,696

   160,500

2,375,499

          50,467

2,425,966

 

For the six months ended 30 September 2018

Attributable to owners of the Parent Company

 

 

 

 

 

 

Other

 

Non-

 

 

Share

Share

Retained

reserves

 

controlling

Total

 

capital

premium

earnings

(note 10)

Total

interests

equity

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

 

 

 

 

At 1 April 2018

        15,455

280,533

1,237,937

   108,733

1,642,658

          35,259

1,677,917

IFRS 9 transition adjustment

-

-

          (3,450)

           -

          (3,450)

               -

   (3,450)

At 1 April 2018 (restated)

        15,455

280,533

1,234,487

   108,733

1,639,208

          35,259

1,674,467

Profit for the period

-

-

        68,002

           -

        68,002

             3,852

    71,854

Currency translation

                    -   

                        -    

              -

      37,512

        37,512

        493

38,005

Group defined benefit pension obligations:

                       

                            

                        

 

                        

 

 

- remeasurements

                   -

-

           2,928

                 -

           2,928

                        -

          2,928

- movement in deferred tax asset

                      -

-

              (489)

                    -

              (489)

                        -

             (489)

Movements relating to cash flow hedges

                      -

-

                      -

      26,532

        26,532

                        -

        26,532

Movement in deferred tax liability on cash flow hedges

                      -

-

                      -

       (4,510)

          (4,510)

                        -

         (4,510)

Total comprehensive income

                      -

-

        70,441

      59,534

     129,975

             4,345

     134,320

Re-issue of treasury shares

                      -

1,054

                      -

                    -

           1,054

                        -

           1,054

Share based payment

                      -

-

                      -

         2,432

           2,432

                        -

           2,432

Dividends

                      -

-

       (73,192)

                    -

       (73,192)

                        -

       (73,192)

At 30 September 2018

        15,455

281,587

1,231,736

   170,699

1,699,477

          39,604

1,739,081

 

For the year ended 31 March 2019

Attributable to owners of the Parent Company

 

 

 

 

 

 

Other

 

Non-

 

 

Share

Share

Retained

reserves

 

controlling

Total

 

capital

premium

earnings

(note 10)

Total

interests

equity

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

 

 

 

 

At 1 April 2018

        15,455

280,533

1,237,937

   108,733

1,642,658

          35,259

1,677,917

IFRS 9 transition adjustment

-

-

          (3,349)

                    -

          (3,349)

                        -

         (3,349)

At 1 April 2018 (restated)

        15,455

280,533

1,234,588

   108,733

1,639,309

          35,259

1,674,568

Profit for the period

-

-

     262,593

                    -

     262,593

             8,539

     271,132

Currency translation

                      -

-

                      -

        6,626

           6,626

               (977)

           5,649

Group defined benefit pension obligations:

                       

                            

                        

 

                        

 

 

- remeasurements

                      -

-

          (1,346)

                    -

          (1,346)

                        -

         (1,346)

- movement in deferred tax asset

                      -

-

                223

                    -

                223

                        -

               223

Movements relating to cash flow hedges

                      -

-

                      -

        1,555

           1,555

                       - 

           1,555

Movement in deferred tax liability on cash flow hedges

                      -

-

                      -

           (264)

              (264)

                        -

             (264)

Total comprehensive income

                      -

-

     261,470

        7,917

     269,387

             7,562

     276,949

Issue of share capital

           1,967

          600,970

       (10,847)

                    -

     592,090

                        -

     592,090

Re-issue of treasury shares

                      -

1,058

                      -

                    -

           1,058

                        -

           1,058

Share based payment

                      -

-

                      -

        5,823

           5,823

                        -

           5,823

Dividends

                      -

-

    (116,961)

                    -

    (116,961)

                        -

    (116,961)

At 31 March 2019

        17,422

882,561

1,368,250

  122,473

2,390,706

          42,821

2,433,527

 

 

Group Cash Flow Statement

 

 

Unaudited

 

Unaudited

 

Audited

 

 

6 months

 

6 months

 

year

 

 

ended

 

ended

 

ended

 

 

30 Sept.

 

30 Sept.

 

31 March

 

 

2019

 

2018

 

2019

 

Notes

£'000

 

£'000

 

£'000

Cash flows from operating activities

 

 

 

 

 

 

Profit for the period

 

42,193

 

71,854

 

271,132

Add back non-operating expenses/(income)

 

 

 

 

 

 

-  tax

 

15,370

 

14,024

 

56,302

-  share of equity accounted investments' profit

 

(469)

 

(248)

 

(717)

-  net operating exceptionals

 

45,329

 

10,291

 

28,185

-  net finance costs

 

27,474

 

18,428

 

42,308

Group operating profit before exceptionals

 

129,897

 

114,349

 

397,210

Share-based payments expense

 

3,686

 

2,432

 

5,823

Depreciation

 

87,964

 

54,434

 

109,626

Amortisation of intangible assets

 

32,664

 

27,569

 

63,312

Profit on disposal of property, plant and equipment

 

(1,347)

 

(863)

 

(2,182)

Amortisation of government grants

 

(6)

 

(34)

 

(40)

Other

 

(4,822)

 

1,049

 

(3,709)

(Increase)/decrease in working capital

 

(98,133)

 

(25,717)

 

37,465

Cash generated from operations before exceptionals

 

149,903

 

173,219

 

607,505

Exceptionals

 

(12,600)

 

(19,626)

 

(34,619)

Cash generated from operations

 

137,303

 

153,593

 

572,886

Interest paid (including lease interest)

 

(41,877)

 

(39,142)

 

(78,031)

Income tax paid

 

(30,221)

 

(12,780)

 

(34,500)

Net cash flows from operating activities

 

65,205

 

101,671

 

460,355

 

 

 

 

 

 

 

Investing activities

 

 

 

 

 

 

Inflows:

 

 

 

 

 

 

Proceeds from disposal of property, plant and equipment

 

4,282

 

4,252

 

8,810

Dividends received from equity accounted investments

 

-

 

-

 

420

Disposal of subsidiaries and equity accounted investments

 

38,040

 

8,573

 

8,492

Interest received

 

21,890

 

17,715

 

34,831

 

 

64,212

 

30,540

 

52,553

Outflows:

 

 

 

 

 

 

Purchase of property, plant and equipment

 

(91,984)

 

(86,341)

 

(182,311)

Acquisition of subsidiaries

14

(93,858)

 

(249,259)

 

(266,525)

Payment of accrued acquisition related liabilities

 

(24,462)

 

(21,048)

 

(30,311)

 

 

(210,304)

 

(356,648)

 

(479,147)

Net cash flows from investing activities

 

(146,092)

 

(326,108)

 

(426,594)

 

 

 

 

 

 

 

Financing activities

 

 

 

 

 

 

Inflows:

 

 

 

 

 

 

Proceeds from issue of shares

 

320

 

1,054

 

593,148

Net cash inflow on derivative financial instruments

 

43,903

 

-

 

-

Increase in interest-bearing loans and borrowings

 

353,210

 

201,357

 

201,357

Increase in lease creditors

 

-

 

989

 

492

 

 

397,433

 

203,400

 

794,997

Outflows:

 

 

 

 

 

 

Repayment of interest-bearing loans and borrowings

 

(123,700)

 

-

 

(201,357)

Repayment of lease creditors

 

(27,565)

 

(53)

 

(630)

Dividends paid to owners of the Parent Company

9

(90,971)

 

(73,192)

 

(116,961)

 

 

(242,236)

 

(73,245)

 

(318,948)

Net cash flows from financing activities

 

155,197

 

130,155

 

476,049

 

 

 

 

 

 

 

Change in cash and cash equivalents

 

74,310

 

(94,282)

 

509,810

Translation adjustment

 

30,203

 

(900)

 

(8,075)

Cash and cash equivalents at beginning of period

 

1,466,028

 

964,293

 

964,293

Cash and cash equivalents at end of period

 

1,570,541

 

869,111

 

1,466,028

 

 

 

 

 

 

 

Cash and cash equivalents consists of:

 

 

 

 

 

 

Cash and short-term bank deposits

 

1,675,517

 

977,571

 

1,554,093

Overdrafts

 

(104,976)

 

(108,460)

 

(88,065)

 

 

1,570,541

 

869,111

 

1,466,028

The current financial period includes the impact of the adoption of IFRS 16 Leasesthe comparatives have not been restated in accordance with transitional guidelines.  

Notes to the Condensed Financial Statements

for the six months ended 30 September 2019

 

 

1.             Basis of Preparation

 

The Group condensed interim financial statements which should be read in conjunction with the annual financial statements for the year ended 31 March 2019 have been prepared in accordance with the Transparency (Directive 2004/109/EC) Regulations 2007, the related Transparency rules of the Irish Financial Services Regulatory Authority and in accordance with IAS 34 Interim Financial Reporting as adopted by the European Union.

 

The preparation of the interim financial statements requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of certain assets, liabilities, revenues and expenses together with disclosure of contingent assets and liabilities.  Estimates and underlying assumptions are reviewed on an ongoing basis. 

 

These condensed interim financial statements for the six months ended 30 September 2019 and the comparative figures for the six months ended 30 September 2018 are unaudited and have not been reviewed by the Auditors.  The summary financial statements for the year ended 31 March 2019 represent an abbreviated version of the Group's full accounts for that year, on which the Auditors issued an unqualified audit report and which have been filed with the Registrar of Companies

 

 

2.             Accounting Policies

 

The accounting policies and methods of computation adopted in the preparation of the Group condensed interim financial statements are consistent with those applied in the 2019 Annual Report and are described in those financial statements on pages 193 to 201, except for those noted below.

 

The following new standards have been adopted in the current year:

 

IFRS 16 Leases

This standard replaces IAS 17 Leases. The changes under IFRS 16 are significant and predominantly affect lessees, the accounting for which is substantially reformed. The lessor accounting requirements contained in IFRS 16's predecessor, IAS 17, remain largely unchanged. The main impact on lessees is that almost all leases are recognised on the balance sheet as the distinction between operating and finance leases is removed for lessees. Under IFRS 16, an asset (the right to use the leased item) and a liability (the lease creditor) to pay rentals are recognised. The only exemptions are short-term leases and low-value leased assets. The standard introduces new estimates and judgemental thresholds that affect the identification, classification and measurement of lease transactions.

 

The Group adopted IFRS 16 on the transition date of 1 April 2019 using the modified retrospective approach, which means that comparatives do not need to be restated. The Group applied the following practical expedients when applying IFRS 16 to leases previously classified as operating leases under IAS 17:

·      Account for leases ending within 12 months of the date of initial application as short-term leases;

·      Apply a single discount rate to a portfolio of leases with reasonably similar characteristics; and

·      Rely on a previous assessment of whether leases are onerous in accordance with IAS 37 immediately before the date of initial application as an alternative to performing an impairment review.

 

At transition date, the Group calculated the lease commitments outstanding at that date and applied appropriate discount rates to calculate the present value of the lease commitment which was recognised as a creditor and a right-of-use leased asset on the Group's Balance Sheet. The right-of-use leased asset was adjusted for any prepayments, accruals and onerous lease provisions with no adjustment to opening retained earnings. The discount rates applied were arrived at using a methodology to calculate the incremental borrowing rates across the Group. The Group engaged a specialist valuation expert to assist with this process. The weighted average incremental borrowing rate applied to lease creditors on the Consolidated Balance Sheet was 3.0% at 1 April 2019.

 

In the Income Statement, the Group previously recognised operating lease rentals in operating expenses. Under IFRS 16, a right-of-use leased asset is capitalised and depreciated over the term of the lease as an operating expense with an associated finance cost applied annually to the lease creditor. The Group avails of the exemption from capitalising lease costs for short-term leases and low-value assets where the relevant criteria are met; such lease costs continue to be expensed in the Income Statement as incurred. Wholly variable lease payments are also expensed as incurred. See note 12, Leases, for further information.

 

The adoption of IFRS 16 had a material impact on the Group's interim financial statements as follows:

•              Right-of-use leased assets: increase of £297 million on transition at 1 April 2019;

·              Lease creditors: increase of £294 million on transition at 1 April 2019;

•              Adjusted operating profit: increase of £2.7 million in the period;

•              Net finance cost: increase of £4.2 million in the period; and

•              Adjusted earnings per share: decrease of 1.3 pence in the period.

 

 

 

A reconciliation of the operating lease commitment previously reported under IAS 17 to the discounted lease creditor as at 1 April 2019 under IFRS 16 is as follows:

 

 

As at 1 April

 

2019

 

£'000

Operating lease commitment under IAS 17

376,337

Contracts identified as leases under IFRS 16

25,509

Wholly variable leases not capitalised under IFRS 16

(29,749)

Commitments relating to low value leased assets and short-term leases

(5,017)

Existing IAS 17 finance leases

901

Impact of discounting

(72,940)

Discounted lease creditor under IFRS 16 as at 1 April 2019

295,041

 

 

Set out below is the new accounting policy of the Group upon adoption of IFRS 16, Leases:

The Group enters into leases for a range of assets, principally relating to property. These property leases have varying terms and renewal rights, including periodic rent reviews linked with indices. The Group also leases motor vehicles, plant, machinery and other equipment. The terms and conditions of these leases do not impose significant financial restrictions on the Group.

 

A contract contains a lease if it is enforceable and conveys the right to control the use of a specified asset for a period of time in exchange for consideration, which is assessed at inception. A right-of-use asset and lease creditor are recognised at the commencement date for contracts containing a lease, with the exception of leases with a term of 12 months or less, leases where the underlying asset is of low value and leases with associated payments that vary directly in line with usage or sales (such lease costs continue to be expensed in the Income Statement as incurred). The commencement date is the date at which the asset is made available for use by the Group.

 

The lease creditor is initially measured at the present value of the future minimum lease payments, discounted using the incremental borrowing rate over the remaining lease term. Lease payments include fixed payments, variable payments that are dependent on an index known at the commencement date, payments for an optional renewal period and termination option payments, if the Group is reasonably certain to exercise those options. The lease term is the non-cancellable period of the lease adjusted for any renewal or termination options which are reasonably certain to be exercised. Management applies judgement in determining whether it is reasonably certain that a renewal or termination option will be exercised.

 

Incremental borrowing rates are calculated using a portfolio approach, based on the risk profile of the entity holding the lease and the term and currency of the lease.

 

After initial recognition, the lease creditor is measured at amortised cost using the effective interest method. It is remeasured when there is a change in future minimum lease payments or when the Group changes its assessment of whether it is reasonably certain to exercise an option within the contract. A corresponding adjustment is made to the carrying amount of the right-of-use asset.

 

The right-of-use asset is initially measured at cost, which comprises the lease creditor adjusted for any payments made at or before the commencement date, initial direct costs incurred, lease incentives received and an estimate of the cost to dismantle or restore the underlying asset or the site on which it is located at the end of the lease term. The right-of-use asset is depreciated over the lease term and is tested periodically for impairment if an impairment indicator is considered to exist.

 

IFRIC 23 Uncertainty over Income Tax Treatments

This IFRIC clarifies the accounting for uncertainties in income taxes and is applied to the determination of taxable profit (or tax loss), tax bases, unused tax losses, unused tax credits and tax rates, when there is uncertainty over income tax treatments under IAS 12 Income Taxes. The adoption of this IFRIC has had an immaterial impact on the Group's interim financial statements.

 

The following changes to IFRS became effective for the Group during the period but did not result in material changes to the Group's consolidated financial statements:

·      Annual Improvements to IFRS Standards 2015-2017 Cycle

·      Amendments to IAS 19: Plan amendment, curtailment or settlement

·      Amendments to IAS 28: Long-term interests in associates and joint ventures

·      Amendments to IFRS 9: Prepayment features with negative compensation

 

The Group has not applied certain new standards, amendments and interpretations to existing standards that have been issued but are not yet effective. They are either not expected to have a material effect on the consolidated financial statements or they are not currently relevant for the Group.

   

3.            Going Concern

 

Having reassessed the principal risks facing the Group (as detailed on pages 17 to 20 of the 2019 Annual Report), the Directors believe that the Group is well placed to manage these risks successfully.

 

The Directors have a reasonable expectation that DCC plc, and the Group as a whole, has adequate resources to continue in operational existence for the foreseeable future, a period of not less than twelve months from the date of this report.  For this reason, the Directors continue to adopt the going concern basis of accounting in preparing the condensed interim financial statements.

 

4.            Reporting Currency

 

The Group's financial statements are presented in sterling, denoted by the symbol '£'. Results and cash flows of operations based in non-sterling countries have been translated into sterling at average rates for the period, and the related balance sheets have been translated at the rates of exchange ruling at the balance sheet date.  The principal exchange rates used for translation of results and balance sheets into sterling were as follows:

 

 

                       Average rate

 

    Closing rate

 

 

 

        6 months

      6 months

               Year

 

        6 months

      6 months

               Year

 

             ended

           ended

           ended

 

             ended

           ended

           ended

 

          30 Sept.

         30 Sept.

       31 March

 

          30 Sept.

         30 Sept.

       31 March

 

               2019

               2018

               2019

 

               2019

               2018

               2019 

 

            Stg£1=

            Stg£1=

            Stg£1=

 

            Stg£1=

            Stg£1=

            Stg£1=

 

 

 

 

 

 

 

 

Euro

             1.1265

             1.1306

             1.1319

 

             1.1291

             1.1270

             1.1651

Danish Krone

             8.4133

             8.4245

             8.4407

 

             8.4297

             8.4035

             8.6977

Swedish Krona

           11.9717

           11.7550

           11.7467

 

           12.0761

           11.6184

           12.1146

Norwegian Krone

           11.0116

           10.8614

           10.9172

 

           11.1723

           10.6689

           11.2536

US Dollar

             1.2620

             1.3409

             1.3184

 

             1.2294

             1.3046

             1.3090

Hong Kong Dollar

             9.8892

           10.5233

           10.3392

 

             9.6385

           10.2084

           10.2755

                           

 

 

5.             Segmental Reporting

 

DCC is an international sales, marketing and support services group headquartered in Dublin, Ireland. Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating decision maker has been identified as Mr. Donal Murphy, Chief Executive and his executive management team.  The Group is organised into four operating segments: DCC LPG, DCC Retail & Oil, DCC Technology and DCC Healthcare.

 

DCC LPG is a leading liquefied petroleum gas ('LPG') sales and marketing business with presences in Europe, North America and Asia and a developing business in the retailing of natural gas and electricity in Europe.

 

DCC Retail & Oil is a leader in the sales, marketing and retailing of transport fuels and commercial fuels, heating oils and related products and services in Europe.

 

DCC Technology is a leading route-to-market and supply chain partner for global technology brands.

 

DCC Healthcare is a leading healthcare business, providing products and services to healthcare providers and health and beauty brand owners.

 

The chief operating decision maker monitors the operating results of segments separately in order to allocate resources between segments and to assess performance. Segment performance is predominantly evaluated based on operating profit before amortisation of intangible assets and net operating exceptional items. Net finance costs and income tax are managed on a centralised basis and therefore these items are not allocated between operating segments for the purpose of presenting information to the chief operating decision maker and accordingly are not included in the detailed segmental analysis.

 

The consolidated total assets of the Group as at 30 September 2019 amounted to £7.6 billion. This figure was not materially different from the equivalent figure at 31 March 2019 and therefore the related segmental disclosure note has been omitted in accordance with IAS 34 Interim Financial Reporting. Intersegment revenue is not material and thus not subject to separate disclosure.

 

 

An analysis of the Group's performance by segment and geographic location is as follows:

 

 

 

(a)           By operating segment

 

 

 

 

 

                               Unaudited six months ended 30 September 2019

 

     

 

                                                                                                         DCC                           DCC                          DCC                           DCC

                                                                                                         LPG                          Retail & Oil            Technology            Healthcare                    Total                                        

 

£'000

 

£'000

 

          £'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

 

Segment revenue

685,934

 

   4,542,944

 

   1,795,538

 

287,305

 

7,311,721

 

 

 

 

 

 

 

 

 

 

Adjusted operating profit

49,034

 

59,670

 

        25,342

 

28,515

 

      162,561

Amortisation of intangible assets

(15,932)

 

(5,286)

 

         (9,436)

 

(2,010)

 

       (32,664)

Net operating exceptionals (note 6)

(4,075)

 

(969)

 

         (4,526)

 

(35,759)

 

       (45,329)

Operating profit

29,027

 

53,415

 

        11,380

 

(9,254)

 

        84,568

                                                                                                                                                                                                     

 

 

 

 

                        Unaudited six months ended 30 September 2018

       

                                                                                                       DCC                   DCC                              DCC                            DCC 

                                                                                                       LPG                    Retail & Oil                  Technology               Healthcare                 Total                           

 

£'000

 

£'000

 

          £'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

 

Segment revenue

721,410

 

   4,832,561

 

1,588,153

 

      275,885

 

7,418,009

 

 

 

 

 

 

 

 

 

 

Adjusted operating profit

40,915

 

56,288

 

17,767

 

        26,948

 

      141,918

Amortisation of intangible assets

(16,176)

 

(5,258)

 

(2,979)

 

         (3,156)

 

       (27,569)

Net operating exceptionals (note 6)

(2,236)

 

(1,467)

 

(6,034)

 

            (554)

 

       (10,291)

Operating profit

22,503

 

49,563

 

8,754

 

        23,238

 

      104,058

 

 

 

 

 

                                           Audited year ended 31 March 2019

       

                                                                                                           DCC                      DCC                          DCC                             DCC 

                                                                                                           LPG                       Retail & Oil             Technology                Healthcare                Total                         

 

£'000

 

£'000

 

          £'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

 

Segment revenue

1,778,293

 

   9,241,281

 

   3,630,934

 

      576,385

 

15,226,893

 

 

 

 

 

 

 

 

 

 

Adjusted operating profit

201,826

 

133,731

 

64,638

 

        60,327

 

      460,522

Amortisation of intangible assets

(31,525)

 

(10,574)

 

(14,885)

 

         (6,328)

 

      (63,312)

Net operating exceptionals (note 6)

(7,041)

 

(4,063)

 

(16,175)

 

            (906)

 

      (28,185)

Operating profit

163,260

 

119,094

 

33,578

 

        53,093

 

      369,025

 

 

(b)           By geography

The Group has a presence in 20 countries worldwide. The following represents a geographical revenue analysis about the country of domicile (Republic of Ireland) and countries with material revenue.

 

 

 

 

 

 

 

Unaudited

 

Unaudited

 

Audited

 

6 months

 

6 months

 

year

 

ended

 

ended

 

ended

 

30 Sept.

 

30 Sept.

 

31 March

 

2019

 

2018

 

2019

 

£'000

 

£'000

 

            £'000

 

 

 

 

 

 

Republic of Ireland

391,597

 

420,661

 

849,795

United Kingdom

3,345,739

 

3,559,461

 

7,345,634

France

1,403,076

 

1,401,882

 

2,958,479

Other

2,171,309

 

2,036,005

 

4,072,985

 

7,311,721

 

7,418,009

 

15,226,893

    

 

(c)            Disaggregation of revenue

The following table disaggregates revenue by primary geographical market, major revenue lines and timing of revenue recognition. The economic factors within each geographic region which affect the nature, amount, timing and uncertainty of revenue and cash flows within sub categories of LPG, retail & oil and technology products and services are similar. DCC Healthcare revenues have been further disaggregated into two product sub categories reflecting the different economic factors affecting those sub categories.

 

 

 

 

                               Unaudited six months ended 30 September 2019

     

                                                                                                          DCC                          DCC                     DCC                                DCC    

                                                                                                          LPG                          Retail & Oil        Technology                  Healthcare                  Total                               

 

£'000

 

£'000

 

          £'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

 

Republic of Ireland (country of domicile)

48,715

 

176,163

 

120,392

 

46,327

 

391,597

United Kingdom

117,141

 

1,974,964

 

1,036,101

 

217,533

 

3,345,739

France

344,124

 

947,051

 

111,901

 

-

 

1,403,076

Other

175,954

 

1,444,766

 

527,144

 

23,445

 

2,171,309

 

685,934

 

4,542,944

 

1,795,538

 

287,305

 

7,311,721

 

 

 

 

 

 

 

 

 

 

Products transferred at point in time

685,934

 

4,542,944

 

1,795,538

 

287,305

 

7,311,721

Products transferred over time

-

 

-

 

-

 

-

 

-

 

685,934

 

4,542,944

 

1,795,538

 

287,305

 

7,311,721

 

 

 

 

 

 

 

 

 

 

LPG and related products

685,934

 

-

 

-

 

-

 

685,934

Oil and related products

-

 

4,542,944

 

-

 

-

 

4,542,944

Technology products and services

-

 

-

 

1,795,538

 

-

 

1,795,538

Medical and pharmaceutical products

-

 

-

 

-

 

171,666

 

171,666

Nutrition and health & beauty products

-

 

-

 

-

 

115,639

 

115,639

 

685,934

 

4,542,944

 

1,795,538

 

287,305

 

7,311,721

 

 

 

 

                        Unaudited six months ended 30 September 2018

     

                                                                                                          DCC                        DCC                            DCC                        DCC               

                                                                                                           LPG                      Retail & Oil                Technology        Healthcare                       Total                            

 

£'000

 

£'000

 

          £'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

 

Republic of Ireland (country of domicile)

53,009

 

166,802

 

159,525

 

41,325

 

420,661

United Kingdom

119,415

 

2,131,002

 

1,095,321

 

213,723

 

3,559,461

France

354,263

 

955,507

 

92,112

 

-

 

1,401,882

Other

194,723

 

1,579,250

 

241,195

 

20,837

 

2,036,005

 

721,410

 

4,832,561

 

1,588,153

 

275,885

 

7,418,009

 

 

 

 

 

 

 

 

 

 

Products transferred at point in time

721,410

 

4,832,561

 

1,588,153

 

275,885

 

7,418,009

Products transferred over time

-

 

-

 

-

 

-

 

-

 

721,410

 

4,832,561

 

1,588,153

 

275,885

 

7,418,009

 

 

 

 

 

 

 

 

 

 

LPG and related products

721,410

 

-

 

-

 

-

 

721,410

Oil and related products

-

 

4,832,561

 

-

 

-

 

4,832,561

Technology products and services

-

 

-

 

1,588,153

 

-

 

1,588,153

Medical and pharmaceutical products

-

 

-

 

-

 

166,813

 

166,813

Nutrition and health & beauty products

-

 

-

 

-

 

109,072

 

109,072

 

721,410

 

4,832,561

 

1,588,153

 

275,885

 

7,418,009

  

 

 

 

                                                 Audited year ended 31 March 2019

     

                                                                                                        DCC                                DCC                              DCC             DCC          

                                                                                                        LPG                       Retail & Oil                Technology       Healthcare                           Total                             

 

£'000

 

£'000

 

          £'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

 

Republic of Ireland (country of domicile)

128,086

 

365,814

 

268,795

 

87,100

 

849,795

United Kingdom

298,731

 

4,125,047

 

2,477,365

 

444,491

 

7,345,634

France

911,829

 

1,835,326

 

211,324

 

-

 

2,958,479

Other

439,647

 

2,915,094

 

673,450

 

44,794

 

4,072,985

 

1,778,293

 

9,241,281

 

3,630,934

 

576,385

 

15,226,893

 

 

 

 

 

 

 

 

 

 

Products transferred at point in time

1,778,293

 

9,241,281

 

3,630,934

 

576,385

 

15,226,893

Products transferred over time

-

 

-

 

-

 

-

 

-

 

1,778,293

 

9,241,281

 

3,630,934

 

576,385

 

15,226,893

 

 

 

 

 

 

 

 

 

 

LPG and related products

1,778,293

 

-

 

-

 

-

 

1,778,293

Oil and related products

-

 

9,241,281

 

-

 

-

 

9,241,281

Technology products and services

-

 

-

 

3,630,934

 

-

 

3,630,934

Medical and pharmaceutical products

-

 

-

 

-

 

344,955

 

344,955

Nutrition and health & beauty products

-

 

-

 

-

 

231,430

 

231,430

 

1,778,293

 

9,241,281

 

3,630,934

 

576,385

 

15,226,893

 

 

6.             Exceptionals

 

Unaudited

 

Unaudited

 

Audited

 

6 months

 

6 months

 

year

 

ended

 

ended

 

ended

 

30 Sept.

 

30 Sept.

 

31 March

 

2019

 

2018

 

2019

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

Restructuring costs

(6,233)

 

(5,124)

 

(19,430)

Acquisition and related costs

(4,939)

 

(5,123)

 

(9,564)

Loss on disposal

(34,265)

 

-

 

-

Adjustments to contingent acquisition consideration

211

 

49

 

1,727

Other operating exceptional items

(103)

 

(93)

 

(918)

Net operating exceptional items

(45,329)

 

(10,291)

 

(28,185)

 

 

 

 

 

 

Mark to market of swaps and related debt

(371)

 

3,974

 

4,307

Net exceptional items before taxation

(45,700)

 

(6,317)

 

(23,878)

 

 

 

 

 

 

Deferred tax

44

 

(628)

 

(685)

Net exceptional items after taxation

(45,656)

 

(6,945)

 

(24,563)

 

 

 

 

 

 

Non-controlling interest share of net exceptional items after taxation

39

 

-

 

-

Net exceptional items attributable to owners of the Parent Company

(45,617)

 

(6,945)

 

(24,563)

 

In September 2019, DCC Healthcare completed the disposal of DCC Vital's UK generic pharma activities and related manufacturing facility in Ireland (Kent Pharma and Athlone Laboratories). The disposal sharpens the strategic focus of DCC Vital, allowing it to concentrate on those areas where it has market-leading positions and sustainable competitive advantage, in particular in the sales, marketing and distribution of medical products in Britain and Ireland. Whilst part of the DCC Group, the cashflows generated by the disposed business more than recovered its acquisition cost, however, the transaction will result in a loss on disposal of £34.265 million, principally representing a non-cash impairment of the goodwill recognised on the initial acquisition of the business.

  

Restructuring and integration costs of £6.233 million principally comprise the ongoing dual running costs relating to the UK SAP implementation which is live in an element of the UK business and to which the remaining components of the business will transition on a phased basis shortly following the end of the financial year. It also includes a restructuring charge relating to the LPG business in Britain, following acquisition activity (including the acquisition of Countrywide and a number of small dealers) in prior periods.

 

Acquisition and related costs include the professional fees and tax costs (such as stamp duty) relating to the evaluation and/or completion of acquisition opportunities and amounted to £4.939 million.

 

Most of the Group's debt has been raised in the US private placement market and swapped, where appropriate, using long-term interest and cross currency interest rate derivatives, to both fixed and floating rate sterling and euro. The level of ineffectiveness calculated under IAS 39 on the fair value and cash flow hedge relationships is charged or credited as an exceptional item. In the six months ended 30 September 2019, this amounted to an exceptional non-cash charge of £0.371 million. Following this charge, the cumulative net exceptional charge taken in respect of the Group's outstanding US private placement debt and related hedging instruments is £1.6 million. This, and any subsequent similar non-cash charges or gains, will net to zero over the remaining term of this debt and the related hedging instruments.

 

 

7.             Taxation

 

The taxation expense for the interim period is based on management's best estimate of the weighted average tax rate that is expected to be applicable for the full year. The Group's effective tax rate for the period was 17% (six months ended 30 September 2018: 17% and year ended 31 March 2019: 17%). 

 

 

8.             Earnings per Ordinary Share

 

Unaudited

 

Unaudited

 

Audited

 

6 months

 

6 months

 

year

 

ended

 

ended

 

ended

 

30 Sept.

 

30 Sept.

 

31 March

 

2019

 

2018

 

2019

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

Profit attributable to owners of the Parent

37,687

 

68,002

 

262,593

Amortisation of intangible assets after tax

25,050

 

20,647

 

48,565

Exceptionals after tax

45,617

 

6,945

 

24,563

Adjusted profit after taxation and non-controlling interests

108,354

 

95,594

 

335,721

 

 

 

 

 

 

Basic earnings per ordinary share

Basic earnings per share is calculated by dividing the profit attributable to owners of the Parent Company by the weighted average number of ordinary shares in issue during the period, excluding ordinary shares purchased by the Company and held as treasury shares.  The adjusted figures for basic earnings per ordinary share (a non-GAAP financial measure) are intended to demonstrate the results of the Group after eliminating the impact of amortisation of intangible assets and net exceptionals.

 

 

Unaudited

 

Unaudited

 

Audited

 

6 months

 

6 months

 

year

 

ended

 

ended

 

ended

 

30 Sept.

 

30 Sept.

 

31 March

 

2019

 

2018

 

2019

 

pence

 

pence

 

pence

 

 

 

 

 

 

Basic earnings per ordinary share

38.34p

 

76.15p

 

280.14p

Amortisation of intangible assets after tax

25.48p

 

23.12p

 

51.81p

Exceptionals after tax

46.40p

 

7.78p

 

26.21p

Adjusted basic earnings per ordinary share

110.22p

 

107.05p

 

358.16p

Weighted average number of ordinary shares in issue (thousands)

98,306

 

89,297

 

93,736

 

 

 

 

 

 

 

Diluted earnings per ordinary share

Diluted earnings per ordinary share is calculated by adjusting the weighted average number of ordinary shares outstanding to assume conversion of all dilutive potential ordinary shares. Share options and awards are the Company's only category of dilutive potential ordinary shares. Employee share options and awards, which are performance-based, are treated as contingently issuable shares because their issue is contingent upon satisfaction of specified performance conditions in addition to the passage of time. These contingently issuable shares are excluded from the computation of diluted earnings per ordinary share where the conditions governing exercisability would not have been satisfied as at the end of the reporting period if that were the end of the vesting period.

 

The adjusted figures for diluted earnings per ordinary share (a non-GAAP financial measure) are intended to demonstrate the results of the Group after eliminating the impact of amortisation of intangible assets and net exceptionals.

 

 

Unaudited

 

Unaudited

 

Audited

 

6 months

 

6 months

 

year

 

ended

 

ended

 

ended

 

30 Sept.

 

30 Sept.

 

31 March

 

2019

 

2018

 

2019

 

pence

 

pence

 

pence

 

 

 

 

 

 

Diluted earnings per ordinary share

38.26p

 

76.02p

 

279.73p

Amortisation of intangible assets after tax

25.43p

 

23.08p

 

51.73p

Exceptionals after tax

46.30p

 

7.77p

 

26.17p

Adjusted diluted earnings per ordinary share

109.99p

 

106.87p

 

357.63p

Weighted average number of ordinary shares in issue (dilutive, thousands)

98,514

 

89,451

 

93,874

 

 

 

 

 

 

The earnings used for the purposes of the diluted earnings per ordinary share calculations were £37.687 million (six months ended 30 September 2018: £68.002 million) and £108.354 million (six months ended 30 September 2018: £95.594 million) for the purposes of the adjusted diluted earnings per ordinary share calculations. The weighted average number of ordinary shares used in calculating the diluted earnings per ordinary share for the six months ended 30 September 2019 was 98.514 million (six months ended 30 September 2018: 89.451 million). A reconciliation of the weighted average number of ordinary shares used for the purposes of calculating the diluted earnings per ordinary share amounts is as follows:

 

Unaudited

 

Unaudited

 

Audited

 

6 months

 

6 months

 

year

 

ended

 

ended

 

ended

 

30 Sept.

 

30 Sept.

 

31 March

 

2019

 

2018

 

2019

 

'000

 

'000

 

'000

 

 

 

 

 

 

Weighted average number of ordinary shares in issue

98,306

 

89,297

 

93,736

Dilutive effect of options and awards

208

 

154

 

138

Weighted average number of ordinary shares for diluted earnings per share

98,514

 

89,451

 

93,874

 

 

9.             Dividends

 

 

Unaudited

 

Unaudited

 

Audited

 

 

6 months

 

6 months

 

year

 

 

ended

 

ended

 

ended

 

 

30 Sept.

 

30 Sept.

 

31 March

 

 

2019

 

2018

 

2019

 

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

 

Interim - paid 44.98 pence per share on 12 December 2018

                     -

 

                       -

 

43,853

Final - paid 93.37 pence per share on 18 July 2019

   (paid 82.09 pence per share on 19 July 2018)

 

90,971

 

 

73,192

 

 

73,108

 

 

               90,971

                         

73,192

 

116,961

               

 

On 11 November 2019, the Board approved an interim dividend of 49.48p pence per share (£48.662 million). These condensed interim financial statements do not reflect this dividend payable. 

  

 

10.          Other Reserves

 

 

 

 

 

 

For the six months ended 30 September 2019

 

 

 

 

 

 

 

 

Foreign

 

 

 

Share based

Cash flow

currency

 

 

 

payment

hedge

translation

Other

 

 

reserve

reserve

reserve

reserves

Total

 

£'000

£'000

£'000

£'000

£'000

 

                   

                   

 

 

 

At 1 April 2019

28,706

(14,887)

107,722

932

122,473

 

 

 

 

 

 

Currency translation

-

-

42,393

-

42,393

Movements relating to cash flow hedges

-

(9,702)

-

-

(9,702)

Movement in deferred tax liability on cash flow hedges                  -

1,650

-

-

1,650

Share based payment

3,686

-

-

-

3,686

At 30 September 2019

32,392

(22,939)

150,115

932

160,500

 

 

For the six months ended 30 September 2018

 

 

 

 

 

 

 

Foreign

 

 

 

Share based

Cash flow

currency

 

 

 

payment

hedge

translation

Other

 

 

reserve

reserve

reserve

reserves

Total

 

£'000

£'000

£'000

£'000

£'000

 

                   

                   

 

 

 

At 1 April 2018

22,883

(16,178)

101,096

932

108,733

 

 

 

 

 

 

Currency translation

-

-

37,512

-

37,512

Movements relating to cash flow hedges

-

26,532

-

-

26,532

Movement in deferred tax liability on cash flow hedges                  -

           (4,510)

-

-

(4,510)

Share based payment

2,432

-

-

-

2,432

At 30 September 2018

25,315

5,844

138,608

932

170,699

 

 

 

 

 

 

 

 

 

 

 

 

For the year ended 31 March 2019

 

 

 

 

 

 

 

 

Foreign

 

 

 

Share based

Cash flow

currency

 

 

 

payment

hedge

translation

Other

 

 

reserve

reserve

reserve

reserves

Total

 

£'000

£'000

£'000

£'000

£'000

 

                   

                   

 

 

 

At 1 April 2018

22,883

(16,178)

101,096

932

108,733

 

 

 

 

 

 

Currency translation

-

-

6,626

-

6,626

Movements relating to cash flow hedges

-

1,555

-

-

1,555

Movement in deferred tax liability on cash flow hedges                  -

        (264)

-

-

(264)

Share based payment

5,823

-

-

-

5,823

At 31 March 2019

28,706

(14,887)

107,722

932

122,473

 

 

 

 

 

 

               

11.          Analysis of Net Debt

 

Unaudited

 

Unaudited

 

Audited

 

30 Sept.

 

30 Sept.

 

31 March

 

2019

 

2018

 

2019

 

£'000

 

£'000

 

£'000

Non-current assets:

 

 

 

 

 

Derivative financial instruments

 

119,661

 

143,554

 

 

 

 

 

 

Current assets:

 

 

 

 

 

Derivative financial instruments

42,331

 

78,232

 

67,987

Cash and cash equivalents

 

977,571

 

1,554,093

 

 

1,055,803

 

    1,622,080

Non-current liabilities:

 

 

 

 

 

Derivative financial instruments

(2,187)

 

(7,489)

 

         (1,122)

Unsecured Notes

 

(1,547,012)

 

  (1,441,904)

 

 

(1,554,501)

 

  (1,443,026)

Current liabilities:

 

 

 

 

 

Derivative financial instruments

(21,985)

 

(12,726)

 

         (9,008)

Bank overdrafts

(104,976)

 

(108,460)

 

       (88,065)

Bank borrowings

-

 

(206,960)

 

                  -

Unsecured Notes

 

(123,164)

 

     (243,059)

 

 

(451,310)

 

     (340,132)

 

Net debt (excluding lease creditors)

 

 

(830,347)

 

 

(17,524)

 

 

 

 

 

 

Lease creditors - non-current*

(232,770)

 

(1,462)

 

(452)

Lease creditors - current*

 

(547)

 

(449)

Total lease creditors

 

(2,009)

 

(901)

 

Net debt (including lease creditors)

 

(531,744)

 

 

(832,356)

 

 

(18,425)

 

 

 

 

 

 

*Lease creditors at 30 September 2018 and 31 March 2019 represent amounts previously disclosed as 'finance leases'.

 

An analysis of the maturity profile of the Group's net debt (including lease creditors) at 30 September 2019 is as follows:

 

 

 

 

 

 

 

 

Between

Between

 

 

 

Less than

1 and 2

         2 and 5

Over

 

 

1 year

years

years

5 years

Total

At 30 September 2019

£'000

£'000

£'000

£'000

£'000

 

                   

                   

 

 

 

Cash and short-term deposits

1,675,517

-

-

-

1,675,517

Overdrafts

(104,976)

-

-

-

(104,976)

Cash and cash equivalents

1,570,541

-

-

-

1,570,541

Unsecured Notes

(193,626)

(116,631)

(691,878)

(1,040,948)

(2,043,083)

Derivative financial instruments - Unsecured Notes

38,375

17,537

132,531

58,974

247,417

Derivative financial instruments - other

(18,029)

(2,180)

-

-

(20,209)

Net debt (excluding lease creditors)                                            1,397,261

(101,274)

(559,347)

(981,974)

(245,334)

 

 

 

 

 

Lease creditors

(53,640)

(40,297)

(76,884)

(115,589)

(286,410)

Net debt (including lease creditors)

1,343,621

(141,571)

(636,231)

(1,097,563)

(531,744)

 

 

 

 

 

 

             

The Group's Unsecured Notes fall due between 24 March 2020 and 4 April 2034 with an average maturity of 6.2 years at 30 September 2019. The full fair value of a hedging derivative is allocated to the time period corresponding to the maturity of the hedged item.

 

 

 

 

 

 

 

12.          Leases

 

The Group adopted IFRS 16 Leases with effect from 1 April 2019. At the date of transition, the Group calculated the lease commitments outstanding at that date and applied appropriate discount rates to calculate the present value of the lease commitment which was recognised as a lease creditor and a right-of-use leased asset on the Group's Balance Sheet.

 

The movement in the Group's right-of-use leased assets during the period is as follows:

 

 

 

Plant,

 

 

Land and

Motor

machinery &

 

 

buildings

vehicles

other

Total

 

£'000

£'000

£'000

£'000

           

 

At 1 April 2019, net carrying amount

-

-

-

-

Effect of adopting IFRS 16

240,413

53,425

2,968

296,806

Translation adjustment

3,806

972

54

4,832

Net additions

8,346

2,472

137

10,955

Arising on acquisition

3,346

-

-

3,346

Depreciation charge for the period

(17,386)

(12,291)

(300)

(29,977)

At 30 September 2019, net carrying amount

238,525

44,578

2,859

285,962

 

 

 

The movement in the Group's lease creditors during the period is as follows:                                                                                £'000

 

 

 

 

 

At 1 April 2019

 

 

 

901

Effect of adopting IFRS 16

 

 

 

294,140

Translation adjustment and other

 

 

 

4,633

Net additions of right-of-use assets

 

 

 

10,955

Arising on acquisition

 

 

 

3,346

Payments

 

 

 

(31,818)

Discount unwinding

 

 

 

4,253

At 30 September 2019

 

 

 

286,410

           

 

 

An analysis of the maturity profile of the discounted lease creditor arising from the Group's leasing activities as at 30 September 2019 is as follows:

 

 

 

 

Unaudited

 

 

 

 

30 Sept.

2019

 

 

 

 

£'000

 

 

 

 

 

Within one year

 

 

 

53,640

Between one and two years

 

 

 

40,297

Between two and five years

 

 

 

76,884

Over 5 years

 

 

 

115,589

Total

 

 

 

286,410

 

 

 

 

 

Analysed as:

 

 

 

 

Non-current liabilities

 

 

 

232,770

Current liabilities

 

 

 

53,640

 

 

 

 

286,410

 

The Group avails of the exemption from capitalising lease costs for short-term leases and low-value assets where the relevant criteria are met. Wholly variable lease payments directly linked to sales or usage are also expensed as incurred. The following lease costs have been charged to the Income Statement as incurred:

 

 

 

 

Unaudited

        6 months

 

 

 

 

ended

 

 

 

 

30 Sept.

2019

 

 

 

 

£'000

 

 

 

 

 

Short-term leases

 

 

 

3,031

Leases of low value assets

 

 

 

52

Wholly variable lease payments

 

 

 

2,938

Total

 

 

 

6,021

 

The total cash outflow for lease payments during the period was as follows:

 

 

 

 

 

 

 

Cash outflow for short-term leases, leases of low value assets and wholly variable lease payments

6,021

Lease payments relating to capitalised right-of-use leased assets

 

31,818

Total cash outflow for lease payments

 

 

 

37,839

 

Lease commitments for short-term leases are similar to the portfolio of short-term leases for which costs were expensed to the Income Statement. The effect of excluding future cash outflows arising from variable lease payments, termination options, residual value guarantees, and leases not yet commenced from lease creditors was not material for the Group. Income from subleasing and gains/losses on sales and leaseback transaction were not material for the Group.

 

 

13.          Post Employment Benefit Obligations

 

The Group's defined benefit pension schemes' assets were measured at fair value at 30 September 2019. The defined benefit pension schemes' liabilities at 30 September 2019 were updated to reflect material movements in underlying assumptions.

 

The Group's post employment benefit obligations moved from a net asset of £1.397 million at 31 March 2019 to a net deficit of £3.200 million at 30 September 2019. This movement was primarily driven by an actuarial loss on liabilities arising from a decrease in the discount rates used to value these liabilities.

 

The following actuarial assumptions have been made in determining the Group's retirement benefit obligation for the six months ended 30 September 2019:

 

Unaudited

 

Unaudited

 

Audited

 

6 months

 

6 months

 

year

 

ended

 

ended

 

ended

 

30 Sept.

 

30 Sept.

 

31 March

 

2019

 

2018

 

2019

Discount rate

 

 

 

 

 

- Republic of Ireland

1.05%

 

2.20%

 

1.75%

- United Kingdom

1.85%

 

2.80%

 

2.50%

- Germany

1.05%

 

2.20%

 

1.75%

 

 

14.          Business Combinations

 

A key strategy of the Group is to create and sustain market leadership positions through acquisitions in markets it currently operates in, together with extending the Group's footprint into new geographic markets. In line with this strategy, the principal acquisitions completed by the Group during the period, together with percentages acquired, were as follows:

·     The acquisition by DCC LPG in April 2019 of 100% of Pacific Coast Energy, an LPG distribution business operating in the north-west of the US;

·     The acquisition by DCC Technology in June 2019 of 75% of Amacom Holding BV ('Amacom'). Amacom is a leading distributor of consumer electronics, AV and IT products, primarily to the retail and e-tail sectors in the Netherlands; and

·     The acquisition by DCC Technology in July 2019 of 100% of Comm-Tec GmbH ('Comm-Tec'). Comm-Tec is a leading value-added distributor of Pro AV and IT products to system integrators and resellers across Germany, Austria, Switzerland, Italy and Spain.

 

The acquisition data presented below reflects the fair value of the identifiable net assets acquired (excluding cash and cash equivalents acquired) in respect of acquisitions completed during the six months ended 30 September 2019.

 

 

 

         6 months

       6 months

 

 

 

 

              ended

            ended

 

 

 

 

           30 Sept.

          30 Sept.

 

 

 

 

2019

2018

 

 

 

 

£'000

£'000

 

Assets

 

 

 

 

 

Non-current assets

 

 

 

 

 

Property, plant and equipment

 

 

10,892

13,894

 

Right-of-use leased assets

 

 

3,346

-

 

Equity accounted investments

 

 

1,802

-

 

Total non-current assets

 

 

16,040

13,894

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

Inventories

 

 

30,237

105,207

 

Trade and other receivables

 

 

40,442

139,044

 

Total current assets

 

 

70,679

244,251

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

Deferred income tax liabilities

 

 

(104)

(447)

 

Lease creditors

 

 

(2,494)

-

 

Provisions for liabilities and charges

 

 

(76)

(2,128)

 

Total non-current liabilities

 

 

(2,674)

(2,575)

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

Trade and other payables

 

 

(38,653)

(119,376)

 

Current income tax (liability)/asset

 

 

(84)

233

 

Lease creditors

 

 

(852)

-

 

Government grants

 

 

-

(147)

 

Total current liabilities

 

 

(39,589)

(119,290)

 

 

 

 

 

 

 

Identifiable net assets acquired

 

 

44,456

136,280

 

Intangible assets - goodwill

 

 

72,534

146,318

 

Total consideration

 

 

116,990

282,598

 

 

 

 

 

 

 

Satisfied by:

 

 

 

 

 

Cash

 

 

81,226

256,796

 

Cash and cash equivalents acquired

 

 

12,632

(7,537)

 

Net cash outflow

 

 

93,858

249,259

 

Acquisition related liabilities

 

 

23,132

33,339

 

Total consideration

 

 

116,990

282,598

 

 

 

None of the business combinations completed during the period were considered sufficiently material to warrant separate disclosure of the fair values attributable to those combinations. 

 

There were no adjustments made to the carrying amounts of assets and liabilities acquired in arriving at their fair values. The initial assignment of fair values to identifiable net assets acquired has been performed on a provisional basis in respect of a number of the business combinations above given the timing of closure of these transactions. Any amendments to these fair values within the twelve-month timeframe from the date of acquisition will be disclosable in the Group's condensed interim financial statements for the six months ending 30 September 2020 as stipulated by IFRS 3.

 

The principal factors contributing to the recognition of goodwill on business combinations entered into by the Group are the expected profitability of the acquired business and the realisation of cost savings and synergies with existing Group entities.

 

Acquisition and related costs included in other operating expenses in the Group Income Statement amounted to £4.939 million (six months ended 30 September 2018: £5.123 million).

 

No contingent liabilities were recognised on the acquisitions completed during the financial period or the prior financial years.

 

The gross contractual value of trade and other receivables as at the respective dates of acquisition amounted to £40.608 million. The fair value of these receivables is £40.442 million (all of which is expected to be recoverable).

 

Approximately £26.3 million of the goodwill recognised in respect of acquisitions completed during the period is expected to be deductible for tax purposes.

 

The fair value of contingent consideration recognised at the date of acquisition is calculated by discounting the expected future payment to present value at the acquisition date. In general, for contingent consideration to become payable, pre-defined profit thresholds must be exceeded.  On an undiscounted basis, the future payments for which the Group may be liable for acquisitions completed during the period range from nil to £46.0 million.

 

The acquisitions during the period contributed £77.9 million to revenues and £2.9 million to profit after tax. Had all the business combinations effected during the period occurred at the beginning of the period, total Group revenue for the six months ended 30 September 2019 would have been £7,365.7 million and total Group profit after tax would have been £43.3 million.

 

 

15.          Seasonality of Operations

 

The Group's operations are significantly second-half weighted primarily due to a portion of the demand for DCC's LPG and Retail & Oil products being weather dependent and seasonal buying patterns in DCC Technology.

 

 

16.          Related Party Transactions

 

There have been no related party transactions or changes in the nature and scale of the related party transactions described in the 2019 Annual Report that could have had a material impact on the financial position or performance of the Group in the six months ended 30 September 2019.

 

 

17.          Events after the Balance Sheet Date

 

In November 2019, DCC Healthcare acquired Ion Laboratories, Inc, a Florida-based contract manufacturer of nutritional products for an enterprise value of approximately US$60 million. An initial assignment of fair values to identifiable net assets acquired has not been completed given the timing of the closure of this transaction.

 

 

18.          Board Approval

 

This report was approved by the Board of Directors of DCC plc on 11 November 2019.

 

 

19.          Distribution of Interim Report

 

This report and further information on DCC is available at the Company's website www.dcc.ie.  A printed copy is available to the public at the Company's registered office at DCC House, Leopardstown Road, Foxrock, Dublin 18, Ireland.

 

 

Statement of Directors' Responsibilities

 

We confirm that to the best of our knowledge:

 

·     the condensed set of interim financial statements for the six months ended 30 September 2019 have been prepared in accordance with IAS 34 Interim Financial Reporting as adopted by the EU; and

 

·     the interim management report includes a fair review of the information required by:

‒ Regulation 8(2) of the Transparency (Directive 2004/109/EC) Regulations 2007, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

‒ Regulation 8(3) of the Transparency (Directive 2004/109/EC) Regulations 2007, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the entity during that period; and any changes in the related party transactions described in the last annual report that could do so.

 

 

 

On behalf of the Board

 

 

John Moloney                                                                            Donal Murphy

Chairman                                                                                    Chief Executive

 

11 November 2019

 

 

 

 

Supplementary Financial Information

 

Alternative Performance Measures

 

The Group reports certain alternative performance measures ('APMs') that are not required under International Financial Reporting Standards ('IFRS') which represent the generally accepted accounting principles ('GAAP') under which the Group reports. The Group believes that the presentation of these APMs provides useful supplemental information which, when viewed in conjunction with our IFRS financial information, provides investors with a more meaningful understanding of the underlying financial and operating performance of the Group and its divisions.

 

These APMs are primarily used for the following purposes:

•  to evaluate the historical and planned underlying results of our operations;

•  to set director and management remuneration; and

•  to discuss and explain the Group's performance with the investment analyst community.

 

None of the APMs should be considered as an alternative to financial measures derived in accordance with GAAP. The APMs can have limitations as analytical tools and should not be considered in isolation or as a substitute for an analysis of our results as reported under GAAP. These performance measures may not be calculated uniformly by all companies and therefore may not be directly comparable with similarly titled measures and disclosures of other companies.

 

The principal APMs used by the Group, together with reconciliations where the non-GAAP measures are not readily identifiable from the financial statements, are as follows:

 

 

Adjusted operating profit ('EBITA')

Definition

This comprises operating profit as reported in the Group Income Statement before net operating exceptional items and amortisation of intangible assets. Net operating exceptional items and amortisation of intangible assets are excluded in order to assess the underlying performance of our operations. In addition, neither metric forms part of Director or management remuneration targets.

 

 

6 months ended

6 months ended

 

Year ended

 

30 Sept.

30 Sept.

31 March

 

2019

2018

2019

 

£'000

£'000

£'000

Operating profit

84,568

104,058

369,025

Net operating exceptional items

45,329

10,291

28,185

Amortisation of intangible assets

32,664

27,569

63,312

Adjusted operating profit ('EBITA')

162,561

141,918

460,522

 

 

Net interest

Definition

The Group defines net interest as the net total of finance costs and finance income before interest related exceptional items as presented in the Group Income Statement.

 

 

6 months ended

6 months ended

 

Year ended

 

30 Sept.

30 Sept.

31 March

 

2019

2018

2019

 

£'000

£'000

£'000

Finance costs before exceptional items

(49,427)

(40,122)

(83,595)

Finance income before exceptional items

22,324

17,720

36,980

Net interest

(27,103)

(22,402)

(46,615)

 

 

Constant currency

Definition

The translation of foreign denominated earnings can be impacted by movements in foreign exchange rates versus sterling, the Group's presentation currency. In order to present a better reflection of underlying performance in the period, the Group retranslates foreign denominated current year earnings at prior year exchange rates.

 

 

 

 

Restated

 

 

6 months ended

6 months ended

 

 

30 Sept.

30 Sept.

 

 

2019

2018

Calculation: Revenue - constant currency

 

£'000

£'000

Revenue

 

7,311,721

7,418,009

Currency impact

 

(18,446)

-

Revenue - constant currency

 

7,293,275

7,418,009

 

 

 

 

6 months ended

6 months ended

 

 

30 Sept.

30 Sept.

 

 

2019

2018

Calculation: Adjusted operating profit - constant currency

 

£'000

£'000

Adjusted operating profit

 

162,561

141,918

Currency impact

 

(1,268)

-

Adjusted operating profit - constant currency

 

161,293

141,918

 

 

Effective tax rate

Definition

The Group's effective tax rate expresses the income tax expense before exceptionals and deferred tax attaching to the amortisation of intangible assets as a percentage of EBITA less net interest.

 

 

6 months ended

6 months ended

 

Year ended

 

30 Sept.

30 Sept.

31 March

 

2019

2018

2019

 

£'000

£'000

£'000

Adjusted operating profit

162,561

141,918

460,522

Net interest

(27,103)

(22,402)

(46,615)

Earnings before taxation

135,458

119,516

413,907

 

Income tax expense

 

15,370

 

14,024

 

56,302

Exceptional deferred tax

44

(628)

(685)

Deferred tax attaching to amortisation of intangible assets

7,614

6,922

14,747

Total income tax expense before exceptionals and deferred tax attaching to amortisation of intangible assets

 

23,028

 

20,318

 

70,364

Effective tax rate (%)

17.0%

17.0%

17.0%

   

Net capital expenditure

Definition

Net capital expenditure comprises purchases of property, plant and equipment, proceeds from the disposal of property, plant and equipment and government grants received in relation to property, plant and equipment.

 

 

6 months ended

6 months ended

 

Year ended

 

30 Sept.

30 Sept.

31 March

 

2019

2018

2019

 

£'000

£'000

£'000

Purchase of property, plant and equipment

91,984

86,341

182,311

Proceeds from disposal of property, plant and equipment

(4,282)

(4,252)

(8,810)

Net capital expenditure

87,702

82,089

173,501

 

 

Free cash flow

Definition

Free cash flow is defined by the Group as cash generated from operations before exceptional items as reported in the Group Cash Flow Statement after repayment of lease creditors and net capital expenditure. Following the adoption of IFRS 16, Leases, the Group has redefined 'free cash flow' to include repayment of lease creditors which ensures that the Group's reported free cash flow is consistent with those measures previously reported and consequently the comparative measures have not been restated.

 

 

6 months ended

6 months ended

 

Year ended

 

30 Sept.

30 Sept.

31 March

 

2019

2018

2019

 

£'000

£'000

£'000

Cash generated from operations before exceptionals

149,903

173,219

607,505

Repayment of lease creditors

(31,818)

-

-

Net capital expenditure

(87,702)

(82,089)

(173,501)

Free cash flow

30,383

91,130

434,004

 

 

Free cash flow (after interest and tax payments)

Definition

Free cash flow (after interest and tax payments) is defined by the Group as free cash flow after interest paid (excluding interest relating to lease creditors), income tax paid, dividends received from equity accounted investments and interest received. As noted in the definition of free cash flow, interest amounts relating to the repayment of lease creditors has been deducted in arriving at the Group's free cash flow and are therefore excluded from the interest paid figure in arriving at the Group's free cash flow (after interest and tax payments).

 

 

6 months ended

6 months ended

 

Year ended

 

30 Sept.

30 Sept.

31 March

 

2019

2018

2019

 

£'000

£'000

£'000

Free cash flow

30,383

91,130

434,004

Interest paid (excluding interest relating to lease creditors)

(37,624)

(39,142)

(78,031)

Income tax paid

(30,221)

(12,780)

(34,500)

Dividends received from equity accounted investments

-

-

420

Interest received

21,890

17,715

34,831

Free cash flow (after interest and tax payments)

(15,572)

56,923

356,724

 

 

Committed acquisition expenditure

Definition

The Group defines committed acquisition expenditure as the total acquisition cost of subsidiaries as presented in the Group Cash Flow Statement (excluding amounts related to acquisitions which were committed to in previous years) and future acquisition related liabilities for acquisitions committed to during the period.

 

 

6 months ended

6 months ended

 

Year ended

 

30 Sept.

30 Sept.

31 March

 

2019

2018

2019

 

£'000

£'000

£'000

Net cash outflow on acquisitions during the period

93,858

249,259

266,525

Net cash outflow on acquisitions which were committed to in the previous period

(75,245)

       (10,488)

(14,750)

Acquisition related liabilities arising on acquisitions during the period

23,132

33,339

29,946

Acquisition related liabilities which were committed to in the previous period

(20,359)

(7,171)

(4,099)

Amounts committed in the current period

54,278

7,000

90,700

Committed acquisition expenditure

75,664

271,939

368,322

         

 

 

Net working capital

Definition

Net working capital represents the net total of inventories, trade and other receivables (excluding interest receivable), and trade and other payables (excluding interest payable, amounts due in respect of property, plant and equipment and current government grants).

 

 

As at

As at

As at

 

30 Sept.

30 Sept.

31 March

 

2019

2018

2019

 

£'000

£'000

£'000

Inventories

736,480

728,648

678,006

Trade and other receivables

1,471,835

1,459,337

1,517,507

Less: interest receivable

(631)

(134)

(193)

Trade and other payables

(2,112,083)

(2,134,197)

(2,218,838)

Less: interest payable

12,335

4,403

5,058

Less: amounts due in respect of property, plant and equipment

2,192

1,912

2,831

Less: government grants

11

11

11

Net working capital

110,139

59,980

(15,618)

 

 

Working capital (days)

Definition

Working capital days measures how long it takes in days for the Group to convert working capital into revenue.

 

 

As at

As at

As at

 

30 Sept.

30 Sept.

31 March

 

2019

2018

2019

 

£'000

£'000

£'000

Net working capital

110,139

59,980

(15,618)

September/March revenue

1,374,838

1,438,866

1,343,551

Working capital (days)

      2.4 days

      1.3 days

     (0.4 days)

 

                                                                                                                        

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR DMMMMGMNGLZZ
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.